|Model|valid-sbml|valid-sbml-units|valid-sedml|broken-ref|tellurium|
|---|---|---|---|---|---|
|n=359|n_fail=15|n_fail=136|n_fail=62|n_fail=67|<details><summary>fails=76</summary>other=2 algebraic=0 delay=0 ASTNode=0 stochiometry=0 float=0 SpeciesRef=0 reset=0 SEDMLfile=62 noSBMLelement=4 CV_ERR_FAILURE=0 CV_TOO_MUCH_WORK=2 CV_CONV_FAILURE=2 CV_ILL_INPUT=1 outOfRange=3</details>|
|[BIOMD0000000005](https://www.ebi.ac.uk/biomodels/BIOMD0000000005)<br/><sup>Tyson1991 - Cell Cycle 6 var</sup>|<details><summary>pass</summary>[BIOMD0000000005_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000005#Files)</details>|pass|<details><summary>FAIL</summary>[BIOMD0000000005_SED-ML.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000005#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file BIOMD0000000005_SED-ML.xml```</details>|
|[BIOMD0000000297](https://www.ebi.ac.uk/biomodels/BIOMD0000000297)<br/><sup>Ciliberto2003_Morphogenesis_Checkpoint</sup>|<details><summary>pass</summary>[BIOMD0000000297_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000297#Files)</details>|pass|<details><summary>pass</summary>[f3.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000297#Files)</details>|pass|<details><summary>FAIL (noSBMLelement)</summary>```No sbml element exists for concentration selection '[IE_a]'```</details>|
|[BIOMD0000000459](https://www.ebi.ac.uk/biomodels/BIOMD0000000459)<br/><sup>Liebal2012 - B.subtilis post-transcriptional instability model</sup>|<details><summary>pass</summary>[BIOMD0000000459_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000459#Files)</details>|pass|<details><summary>FAIL</summary>[BIOMD0000000459-SEDML.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000459#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file BIOMD0000000459-SEDML.xml```</details>|
|[BIOMD0000000460](https://www.ebi.ac.uk/biomodels/BIOMD0000000460)<br/><sup>Liebal2012 - B.subtilis sigB proteolysis model</sup>|<details><summary>pass</summary>[BIOMD0000000460_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000460#Files)</details>|pass|<details><summary>FAIL</summary>[BIOMD0000000460-SEDML.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000460#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file BIOMD0000000460-SEDML.xml```</details>|
|[BIOMD0000000461](https://www.ebi.ac.uk/biomodels/BIOMD0000000461)<br/><sup>Liebal2012 - B.subtilis transcription inhibition model</sup>|<details><summary>pass</summary>[BIOMD0000000461_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000461#Files)</details>|pass|<details><summary>FAIL</summary>[BIOMD0000000461-SEDML.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000461#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file BIOMD0000000461-SEDML.xml```</details>|
|[BIOMD0000000539](https://www.ebi.ac.uk/biomodels/BIOMD0000000539)<br/><sup>François2005 - Mixed Feedback Loop (two-gene network)</sup>|<details><summary>pass</summary>[BIOMD0000000539_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000539#Files)</details>|pass|<details><summary>FAIL</summary>[BIOMD0000000539.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000539#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file BIOMD0000000539.sedml```</details>|
|[BIOMD0000000546](https://www.ebi.ac.uk/biomodels/BIOMD0000000546)<br/><sup>Miao2010 - Innate and adaptive immune responses to primary Influenza A Virus infection_1_1</sup>|<details><summary>FAIL</summary>[BIOMD0000000546.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000546#Files)</details>|FAIL|<details><summary>pass</summary>[BIOMD0000000546.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000546#Files)</details>|FAIL|pass|
|[BIOMD0000000596](https://www.ebi.ac.uk/biomodels/BIOMD0000000596)<br/><sup>Philipson2015 - Innate immune response modulated by NLRX1</sup>|<details><summary>FAIL</summary>[Philipson2015.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000596#Files)</details>|FAIL|<details><summary>pass</summary>[Philipson2015.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000596#Files)</details>|pass|pass|
|[BIOMD0000000618](https://www.ebi.ac.uk/biomodels/BIOMD0000000618)<br/><sup>Krohn2011 - Cerebral amyloid-β proteostasis regulated by membrane transport protein ABCC1</sup>|<details><summary>pass</summary>[BIOMD0000000618_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000618#Files)</details>|pass|<details><summary>FAIL</summary>[BIOMD0000000618_SED-ML.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000618#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file BIOMD0000000618_SED-ML.xml```</details>|
|[BIOMD0000000623](https://www.ebi.ac.uk/biomodels/BIOMD0000000623)<br/><sup>Orton2009 - Modelling cancerous mutations in the EGFR/ERK pathway - EGF Model</sup>|<details><summary>pass</summary>[BIOMD0000000623_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000623#Files)</details>|pass|<details><summary>pass</summary>[Orton2009.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000623#Files)</details>|pass|pass|
|[BIOMD0000000627](https://www.ebi.ac.uk/biomodels/BIOMD0000000627)<br/><sup>Winter2017 - Brain Energy Metabolism with PPP</sup>|<details><summary>pass</summary>[BIOMD0000000627_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000627#Files)</details>|pass|<details><summary>FAIL</summary>[BIOMD0000000627_SED-ML.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000627#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file BIOMD0000000627_SED-ML.xml```</details>|
|[BIOMD0000000643](https://www.ebi.ac.uk/biomodels/BIOMD0000000643)<br/><sup>Musante2017 - Switching behaviour of PP2A inhibition by ARPP-16 - mutual inhibitions</sup>|<details><summary>pass</summary>[BIOMD0000000643_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000643#Files)</details>|pass|<details><summary>FAIL</summary>[ARPP-16_Layer1_mutualInhibitions.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000643#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file ARPP-16_Layer1_mutualInhibitions.sedml```</details>|
|[BIOMD0000000644](https://www.ebi.ac.uk/biomodels/BIOMD0000000644)<br/><sup>Musante2017 - Switching behaviour of PP2A inhibition by ARPP-16 - mutual inhibitions and PKA inhibits MAST3</sup>|<details><summary>pass</summary>[BIOMD0000000644_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000644#Files)</details>|pass|<details><summary>FAIL</summary>[ARPP-16_Layer1and2_mutualInhibitions_PKAinhibitsMAST3.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000644#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file ARPP-16_Layer1and2_mutualInhibitions_PKAinhibitsMAST3.sedml```</details>|
|[BIOMD0000000645](https://www.ebi.ac.uk/biomodels/BIOMD0000000645)<br/><sup>Musante2017 - Switching behaviour of PP2A inhibition by ARPP-16 - mutual inhibitions and PKA inhibits MAST3 and dominant negative effect</sup>|<details><summary>pass</summary>[BIOMD0000000645_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000645#Files)</details>|pass|<details><summary>FAIL</summary>[ARPP-16_Layer1and2and3_mutualInhibitions_PKAinhibitsMAST3_dominantNegative.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000645#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file ARPP-16_Layer1and2and3_mutualInhibitions_PKAinhibitsMAST3_dominantNegative.sedml```</details>|
|[BIOMD0000000646](https://www.ebi.ac.uk/biomodels/BIOMD0000000646)<br/><sup>Barr2016 - All-or-nothing G1/S transition</sup>|<details><summary>pass</summary>[BIOMD0000000646_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000646#Files)</details>|pass|<details><summary>FAIL</summary>[Barr2016.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000646#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Barr2016.sedml```</details>|
|[BIOMD0000000647](https://www.ebi.ac.uk/biomodels/BIOMD0000000647)<br/><sup>Kwang2003 - The influence of RKIP on the ERK signaling pathway</sup>|<details><summary>pass</summary>[BIOMD0000000647_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000647#Files)</details>|pass|<details><summary>FAIL</summary>[BIOMD0000000647.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000647#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file BIOMD0000000647.sedml```</details>|
|[BIOMD0000000650](https://www.ebi.ac.uk/biomodels/BIOMD0000000650)<br/><sup>Owen1998 - Tumour  treatment model</sup>|<details><summary>pass</summary>[BIOMD0000000650_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000650#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1708250002_treatment_start10.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000650#Files)</details>|pass|<details><summary>FAIL (other)</summary>```'NoneType' object is not subscriptable```</details>|
|[BIOMD0000000651](https://www.ebi.ac.uk/biomodels/BIOMD0000000651)<br/><sup>Nguyen2016 - Feedback regulation in cell signalling: Lessons for cancer therapeutics</sup>|<details><summary>pass</summary>[BIOMD0000000651_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000651#Files)</details>|pass|<details><summary>FAIL</summary>[BIOMD0000000651.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000651#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file BIOMD0000000651.sedml```</details>|
|[BIOMD0000000658](https://www.ebi.ac.uk/biomodels/BIOMD0000000658)<br/><sup>Lee2003 - Roles of APC and Axin in Wnt Pathway (without regulatory loop)</sup>|<details><summary>pass</summary>[BIOMD0000000658_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000658#Files)</details>|pass|<details><summary>pass</summary>[MODEL1708310000_edited.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000658#Files)</details>|pass|pass|
|[BIOMD0000000661](https://www.ebi.ac.uk/biomodels/BIOMD0000000661)<br/><sup>Webb2002 - Fas/FasL mediated tumor T-cell interaction</sup>|<details><summary>pass</summary>[BIOMD0000000661_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000661#Files)</details>|pass|<details><summary>FAIL</summary>[MODEL1006230046.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000661#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file MODEL1006230046.sedml```</details>|
|[BIOMD0000000662](https://www.ebi.ac.uk/biomodels/BIOMD0000000662)<br/><sup>Moore2004 - Chronic Myeloid Leukemic cells and T-lymphocyte interaction</sup>|<details><summary>pass</summary>[BIOMD0000000662_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000662#Files)</details>|FAIL|<details><summary>pass</summary>[Moore2004.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000662#Files)</details>|pass|pass|
|[BIOMD0000000663](https://www.ebi.ac.uk/biomodels/BIOMD0000000663)<br/><sup>Wodarz2007 - HIV/CD4 T-cell interaction</sup>|<details><summary>pass</summary>[BIOMD0000000663_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000663#Files)</details>|pass|<details><summary>pass</summary>[Wodarz2007_model_2.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000663#Files)</details>|pass|pass|
|[BIOMD0000000664](https://www.ebi.ac.uk/biomodels/BIOMD0000000664)<br/><sup>Muller2008 - Simplified MAPK activation Dynamics (Model B)</sup>|<details><summary>pass</summary>[BIOMD0000000664_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000664#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL8687732743.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000664#Files)</details>|pass|pass|
|[BIOMD0000000665](https://www.ebi.ac.uk/biomodels/BIOMD0000000665)<br/><sup>Fallon2000 - Interleukin-2 dynamics</sup>|<details><summary>pass</summary>[BIOMD0000000665_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000665#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1006230001.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000665#Files)</details>|pass|pass|
|[BIOMD0000000666](https://www.ebi.ac.uk/biomodels/BIOMD0000000666)<br/><sup>Pappalardo2016 - PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer</sup>|<details><summary>pass</summary>[BIOMD0000000666_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000666#Files)</details>|pass|<details><summary>pass</summary>[BIOMD0000000666.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000666#Files)</details>|pass|pass|
|[BIOMD0000000667](https://www.ebi.ac.uk/biomodels/BIOMD0000000667)<br/><sup>Hornberg2005 - MAPKsignalling</sup>|<details><summary>pass</summary>[BIOMD0000000667_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000667#Files)</details>|pass|<details><summary>pass</summary>[MODEL0848279215.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000667#Files)</details>|pass|pass|
|[BIOMD0000000668](https://www.ebi.ac.uk/biomodels/BIOMD0000000668)<br/><sup>Zhu2015 - Combined gemcitabine and birinapant in pancreatic cancer cells - basic PD model</sup>|<details><summary>pass</summary>[BIOMD0000000668_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000668#Files)</details>|pass|<details><summary>pass</summary>[MODEL1604270000_basic.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000668#Files)</details>|pass|pass|
|[BIOMD0000000669](https://www.ebi.ac.uk/biomodels/BIOMD0000000669)<br/><sup>Zhu2015 - Combined gemcitabine and birinapant in pancreatic cancer cells - mechanistic PD model</sup>|<details><summary>pass</summary>[BIOMD0000000669_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000669#Files)</details>|pass|<details><summary>pass</summary>[MODEL1604270001_mechanistic.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000669#Files)</details>|pass|pass|
|[BIOMD0000000670](https://www.ebi.ac.uk/biomodels/BIOMD0000000670)<br/><sup>Owen1998 - tumour growth model</sup>|<details><summary>pass</summary>[BIOMD0000000670_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000670#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1708240000.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000670#Files)</details>|pass|pass|
|[BIOMD0000000671](https://www.ebi.ac.uk/biomodels/BIOMD0000000671)<br/><sup>Murphy2016 - Differences in predictions of ODE models of tumor growth</sup>|<details><summary>pass</summary>[BIOMD0000000671_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000671#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1708250001.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000671#Files)</details>|pass|pass|
|[BIOMD0000000672](https://www.ebi.ac.uk/biomodels/BIOMD0000000672)<br/><sup>Brown1997 - Plasma Melatonin Levels</sup>|<details><summary>pass</summary>[BIOMD0000000672_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000672#Files)</details>|pass|<details><summary>pass</summary>[MODEL1006230019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000672#Files)</details>|pass|pass|
|[BIOMD0000000673](https://www.ebi.ac.uk/biomodels/BIOMD0000000673)<br/><sup>Lockwood2006 - Alzheimer's Disease PBPK model</sup>|<details><summary>pass</summary>[BIOMD0000000673_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000673#Files)</details>|pass|<details><summary>FAIL</summary>[MODEL1006230054_edited.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000673#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file MODEL1006230054_edited.sedml```</details>|
|[BIOMD0000000674](https://www.ebi.ac.uk/biomodels/BIOMD0000000674)<br/><sup>Reyes-Palomares2012 - a combined model hepatic polyamine and sulfur aminoacid metabolism - version1</sup>|<details><summary>pass</summary>[BIOMD0000000674_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000674#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1305060000_edited.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000674#Files)</details>|pass|pass|
|[BIOMD0000000675](https://www.ebi.ac.uk/biomodels/BIOMD0000000675)<br/><sup>Chen2000_CellCycle</sup>|<details><summary>pass</summary>[BIOMD0000000675.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000675#Files)</details>|pass|<details><summary>FAIL</summary>[MODEL1006230004.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000675#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file MODEL1006230004.sedml```</details>|
|[BIOMD0000000676](https://www.ebi.ac.uk/biomodels/BIOMD0000000676)<br/><sup>Chen2006 - Nitric Oxide Release from Endothelial Cells</sup>|<details><summary>pass</summary>[BIOMD0000000676_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000676#Files)</details>|pass|<details><summary>pass</summary>[MODEL1006230005.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000676#Files)</details>|pass|pass|
|[BIOMD0000000677](https://www.ebi.ac.uk/biomodels/BIOMD0000000677)<br/><sup>Holmes2006 - Hill's model of muscle contraction</sup>|<details><summary>pass</summary>[BIOMD0000000677_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000677#Files)</details>|pass|<details><summary>pass</summary>[MODEL1006230007.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000677#Files)</details>|pass|pass|
|[BIOMD0000000678](https://www.ebi.ac.uk/biomodels/BIOMD0000000678)<br/><sup>Tomida2003 - Calcium Oscillatory-induced translocation of nuclear factor of activated T cells</sup>|<details><summary>pass</summary>[BIOMD0000000678_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000678#Files)</details>|pass|<details><summary>FAIL</summary>[MODEL0912160005.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000678#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file MODEL0912160005.sedml```</details>|
|[BIOMD0000000679](https://www.ebi.ac.uk/biomodels/BIOMD0000000679)<br/><sup>Waugh2006 - Diabetic Wound Healing - Macrophage Dynamics</sup>|<details><summary>pass</summary>[Waugh2006_1.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000679#Files)</details>|FAIL|<details><summary>pass</summary>[Waugh2006_1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000679#Files)</details>|pass|pass|
|[BIOMD0000000680](https://www.ebi.ac.uk/biomodels/BIOMD0000000680)<br/><sup>Waugh2006 - Diabetic Wound Healing - TGF-B Dynamics</sup>|<details><summary>pass</summary>[BIOMD0000000680_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000680#Files)</details>|FAIL|<details><summary>pass</summary>[Waugh2006_2.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000680#Files)</details>|pass|pass|
|[BIOMD0000000681](https://www.ebi.ac.uk/biomodels/BIOMD0000000681)<br/><sup>Waugh2006 - Diabetic Wound Healing - Treated and Untreated Macrophage Dynamics</sup>|<details><summary>pass</summary>[BIOMD0000000681_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000681#Files)</details>|FAIL|<details><summary>pass</summary>[Waugh2006_3.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000681#Files)</details>|pass|pass|
|[BIOMD0000000682](https://www.ebi.ac.uk/biomodels/BIOMD0000000682)<br/><sup>Wierschem2004 - Electrical bursting activity in Pancreatic Islets</sup>|<details><summary>pass</summary>[BIOMD0000000682_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000682#Files)</details>|pass|<details><summary>pass</summary>[MODEL1006230006.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000682#Files)</details>|pass|pass|
|[BIOMD0000000683](https://www.ebi.ac.uk/biomodels/BIOMD0000000683)<br/><sup>Wodarz1999 CTL memory response HIV</sup>|<details><summary>pass</summary>[MODEL1006230062.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000683#Files)</details>|pass|<details><summary>pass</summary>[MODEL1006230062.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000683#Files)</details>|pass|pass|
|[BIOMD0000000684](https://www.ebi.ac.uk/biomodels/BIOMD0000000684)<br/><sup>Wodarz2003 - Immunological Memory</sup>|<details><summary>pass</summary>[BIOMD0000000684_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000684#Files)</details>|pass|<details><summary>pass</summary>[MODEL1006230061.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000684#Files)</details>|pass|pass|
|[BIOMD0000000685](https://www.ebi.ac.uk/biomodels/BIOMD0000000685)<br/><sup>Wodarz2003 - Cytotoxic T lymphocyte cross-priming</sup>|<details><summary>pass</summary>[BIOMD0000000685_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000685#Files)</details>|pass|<details><summary>pass</summary>[MODEL1006230094.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000685#Files)</details>|pass|pass|
|[BIOMD0000000687](https://www.ebi.ac.uk/biomodels/BIOMD0000000687)<br/><sup>Wodarz2007 - Cytomegalovirus infection model with cytotoxic T lymphocyte response</sup>|<details><summary>pass</summary>[BIOMD0000000687_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000687#Files)</details>|pass|<details><summary>pass</summary>[MODEL1006230052.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000687#Files)</details>|pass|pass|
|[BIOMD0000000688](https://www.ebi.ac.uk/biomodels/BIOMD0000000688)<br/><sup>Wodarz2007 - Cytomegalovirus infection model with cytotoxic T lymphocyte and natural killer cell response</sup>|<details><summary>pass</summary>[BIOMD0000000688_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000688#Files)</details>|pass|<details><summary>pass</summary>[MODEL1006230097.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000688#Files)</details>|pass|pass|
|[BIOMD0000000689](https://www.ebi.ac.uk/biomodels/BIOMD0000000689)<br/><sup>Thiaville2016 - Folate pathway model (PanB overexpression)</sup>|<details><summary>pass</summary>[BIOMD0000000689_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000689#Files)</details>|pass|<details><summary>pass</summary>[MODEL1602280002.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000689#Files)</details>|pass|pass|
|[BIOMD0000000690](https://www.ebi.ac.uk/biomodels/BIOMD0000000690)<br/><sup>Thiaville2016 - Folate pathway model (PanB overexpression and THF regulation)</sup>|<details><summary>pass</summary>[BIOMD0000000690_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000690#Files)</details>|pass|<details><summary>pass</summary>[MODEL1602280003.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000690#Files)</details>|pass|pass|
|[BIOMD0000000691](https://www.ebi.ac.uk/biomodels/BIOMD0000000691)<br/><sup>Wolf2000 - Cellular interaction on glycolytic oscillations in yeast</sup>|<details><summary>pass</summary>[BIOMD0000000691_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000691#Files)</details>|pass|<details><summary>pass</summary>[MODEL1006230022.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000691#Files)</details>|pass|<details><summary>FAIL (CV_TOO_MUCH_WORK)</summary>```CVODE Error: CV_TOO_MUCH_WORK: The solver took mxstep (20000) internal steps but could not reach tout.; In virtual double rr::CVODEIntegrator::integrate(double, double)```</details>|
|[BIOMD0000000692](https://www.ebi.ac.uk/biomodels/BIOMD0000000692)<br/><sup>Phillips2003 - The Mechanism of Ras GTPase Activation by Neurofibromin</sup>|<details><summary>pass</summary>[BIOMD0000000692_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000692#Files)</details>|pass|<details><summary>pass</summary>[MODEL4968912141.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000692#Files)</details>|pass|pass|
|[BIOMD0000000693](https://www.ebi.ac.uk/biomodels/BIOMD0000000693)<br/><sup>Wang2008 - Mimicking the inhibitory effect of riluzole on membrane conductance in skeletal fibres</sup>|<details><summary>pass</summary>[BIOMD0000000693_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000693#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL7817907010.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000693#Files)</details>|pass|pass|
|[BIOMD0000000695](https://www.ebi.ac.uk/biomodels/BIOMD0000000695)<br/><sup>FelixGarza2017 - Blue Light Treatment of Psoriasis (simplified)</sup>|<details><summary>pass</summary>[BIOMD0000000695_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000695#Files)</details>|pass|<details><summary>pass</summary>[MODEL1701090001.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000695#Files)</details>|pass|pass|
|[BIOMD0000000696](https://www.ebi.ac.uk/biomodels/BIOMD0000000696)<br/><sup>Boada2016 - Incoherent type 1 feed-forward loop (I1-FFL)</sup>|<details><summary>pass</summary>[BIOMD0000000696_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000696#Files)</details>|pass|<details><summary>pass</summary>[MODEL1511290000.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000696#Files)</details>|pass|<details><summary>FAIL (CV_CONV_FAILURE)</summary>```CVODE Error: CV_CONV_FAILURE: Convergence test failures occurred too many times (= MXNCF = 10) during one internal timestep or occurred with |h| = hmin.; In virtual double rr::CVODEIntegrator::integrate(double, double)```</details>|
|[BIOMD0000000698](https://www.ebi.ac.uk/biomodels/BIOMD0000000698)<br/><sup>Reed2004 - Methionine Cycle</sup>|<details><summary>pass</summary>[BIOMD0000000698_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000698#Files)</details>|pass|<details><summary>pass</summary>[MODEL1006230091.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000698#Files)</details>|pass|pass|
|[BIOMD0000000699](https://www.ebi.ac.uk/biomodels/BIOMD0000000699)<br/><sup>Caydasi2012 - Regulation of Tem1 by the GAP complex in spindle position cell cycle checkpoint - Ubiquitous association model</sup>|<details><summary>pass</summary>[BIOMD0000000699_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000699#Files)</details>|FAIL|<details><summary>FAIL</summary>[MODEL1202090002_Fig5 i.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000699#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file MODEL1202090002_Fig5 i.sedml```</details>|
|[BIOMD0000000700](https://www.ebi.ac.uk/biomodels/BIOMD0000000700)<br/><sup>Heldt2018 - Proliferation-quiescence decision in response to DNA damage</sup>|<details><summary>pass</summary>[BIOMD0000000700_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000700#Files)</details>|pass|<details><summary>pass</summary>[figure1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000700#Files)</details>|pass|pass|
|[BIOMD0000000701](https://www.ebi.ac.uk/biomodels/BIOMD0000000701)<br/><sup>Caydasi2012 - Inhibition of Tem1 by the GAP complex in Spindle Position Checkpoint</sup>|<details><summary>pass</summary>[MODEL1202090001_FINAL.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000701#Files)</details>|FAIL|<details><summary>FAIL</summary>[MODEL1202090001_FINAL.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000701#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file MODEL1202090001_FINAL.sedml```</details>|
|[BIOMD0000000702](https://www.ebi.ac.uk/biomodels/BIOMD0000000702)<br/><sup>Caydasi2012 - Regulation of Tem1 by the GAP complex in Spindle Position Checkpoint - Ubiquitous inactive model</sup>|<details><summary>pass</summary>[BIOMD0000000702_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000702#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1202090003_Fig5 iii.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000702#Files)</details>|pass|pass|
|[BIOMD0000000704](https://www.ebi.ac.uk/biomodels/BIOMD0000000704)<br/><sup>Aguda1999 - G2 DNA damage checkpoint</sup>|<details><summary>pass</summary>[BIOMD0000000704_url.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000704#Files)</details>|pass|<details><summary>pass</summary>[figure8.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000704#Files)</details>|pass|pass|
|[BIOMD0000000719](https://www.ebi.ac.uk/biomodels/BIOMD0000000719)<br/><sup>Tsai2014 - Cell cycle duration control by oscillatory Dynamics  in Early Xenopus laevis Embryos</sup>|<details><summary>pass</summary>[Tsai2014.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000719#Files)</details>|pass|<details><summary>pass</summary>[tsai2014.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000719#Files)</details>|pass|pass|
|[BIOMD0000000724](https://www.ebi.ac.uk/biomodels/BIOMD0000000724)<br/><sup>Theinmozhi2018 - Mechanism of PD1 inhibiting TCR signaling in Tumor immune regulation</sup>|<details><summary>pass</summary>[Theinmozhi_2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000724#Files)</details>|pass|<details><summary>pass</summary>[Theinmozhi_2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000724#Files)</details>|FAIL|pass|
|[BIOMD0000000731](https://www.ebi.ac.uk/biomodels/BIOMD0000000731)<br/><sup>Robertson-Tessi M 2012 A model of tumor Immune interaction</sup>|<details><summary>pass</summary>[22051568_Tessi.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000731#Files)</details>|FAIL|<details><summary>FAIL</summary>[22051568_Tessi.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000731#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file 22051568_Tessi.sedml```</details>|
|[BIOMD0000000732](https://www.ebi.ac.uk/biomodels/BIOMD0000000732)<br/><sup>Kirschner1998_Immunotherapy_Tumour</sup>|<details><summary>pass</summary>[Kirschner_1998.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000732#Files)</details>|FAIL|<details><summary>FAIL</summary>[Kirschner_1998.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000732#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Kirschner_1998.sedml```</details>|
|[BIOMD0000000733](https://www.ebi.ac.uk/biomodels/BIOMD0000000733)<br/><sup>Moore_2004_Mathematical model for CML and T cell interaction</sup>|<details><summary>pass</summary>[Moore_2004_fig6.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000733#Files)</details>|FAIL|<details><summary>pass</summary>[Moore_2004_fig6.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000733#Files)</details>|pass|pass|
|[BIOMD0000000734](https://www.ebi.ac.uk/biomodels/BIOMD0000000734)<br/><sup>Mouse Iron Distribution - Rich and Deficient iron diets (tracer)</sup>|<details><summary>pass</summary>[BIOMD0000000734.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000734#Files)</details>|pass|<details><summary>pass</summary>[Parmar2017_Deficient_Rich_tracer.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000734#Files)</details>|pass|pass|
|[BIOMD0000000735](https://www.ebi.ac.uk/biomodels/BIOMD0000000735)<br/><sup>Mouse Iron Distribution - Adequate iron diet (tracer)</sup>|<details><summary>pass</summary>[Parmar2017_Adequate_tracer.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000735#Files)</details>|pass|<details><summary>pass</summary>[Parmar2017_Adequate_tracer.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000735#Files)</details>|pass|pass|
|[BIOMD0000000736](https://www.ebi.ac.uk/biomodels/BIOMD0000000736)<br/><sup>Mouse Iron Distribution - Adequate iron diet (No Tracer)</sup>|<details><summary>pass</summary>[Parmar2017_Adequate_diet_Anemia_NoTracer.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000736#Files)</details>|pass|<details><summary>pass</summary>[Parmar2017_Adequate_diet_Anemia_NoTracer.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000736#Files)</details>|pass|pass|
|[BIOMD0000000737](https://www.ebi.ac.uk/biomodels/BIOMD0000000737)<br/><sup>Mouse Iron Distribution - Deficient iron diet (No Tracer)</sup>|<details><summary>pass</summary>[Parmar2017_Deficient_NoTracer.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000737#Files)</details>|pass|<details><summary>pass</summary>[Parmar2017_Deficient_NoTracer.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000737#Files)</details>|pass|pass|
|[BIOMD0000000738](https://www.ebi.ac.uk/biomodels/BIOMD0000000738)<br/><sup>Mouse Iron Distribution - Rich iron diet (No Tracer)</sup>|<details><summary>pass</summary>[Parmar2017_Rich_NoTracer.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000738#Files)</details>|pass|<details><summary>pass</summary>[Parmar2017_Rich_NoTracer.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000738#Files)</details>|pass|pass|
|[BIOMD0000000739](https://www.ebi.ac.uk/biomodels/BIOMD0000000739)<br/><sup>Bravo2012 - Modelling blood coagulation factor Va inactivation by APC</sup>|<details><summary>pass</summary>[Bravo2012.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000739#Files)</details>|pass|<details><summary>pass</summary>[Bravo2012.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000739#Files)</details>|pass|pass|
|[BIOMD0000000740](https://www.ebi.ac.uk/biomodels/BIOMD0000000740)<br/><sup>Panteleev2010 - Blood Coagulation: Full Model</sup>|<details><summary>pass</summary>[Panteleev2010_full_model.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000740#Files)</details>|pass|<details><summary>pass</summary>[Panteleev2010_full_model.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000740#Files)</details>|pass|pass|
|[BIOMD0000000741](https://www.ebi.ac.uk/biomodels/BIOMD0000000741)<br/><sup>Eftimie2018 - Cancer and Immune biomarkers</sup>|<details><summary>pass</summary>[Eftimie2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000741#Files)</details>|FAIL|<details><summary>FAIL</summary>[Eftimie2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000741#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Eftimie2018.sedml```</details>|
|[BIOMD0000000742](https://www.ebi.ac.uk/biomodels/BIOMD0000000742)<br/><sup>Garcia2018basic - cancer and immune cell count basic model</sup>|<details><summary>pass</summary>[Garcia2018basic.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000742#Files)</details>|FAIL|<details><summary>FAIL</summary>[Garcia2018basic.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000742#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Garcia2018basic.sedml```</details>|
|[BIOMD0000000743](https://www.ebi.ac.uk/biomodels/BIOMD0000000743)<br/><sup>Gallaher2018 - Tumor–Immune dynamics in multiple myeloma</sup>|<details><summary>pass</summary>[Gallaher2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000743#Files)</details>|FAIL|<details><summary>pass</summary>[Gallaher2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000743#Files)</details>|pass|pass|
|[BIOMD0000000744](https://www.ebi.ac.uk/biomodels/BIOMD0000000744)<br/><sup>Hu2019 - Pancreatic cancer dynamics</sup>|<details><summary>pass</summary>[Hu2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000744#Files)</details>|FAIL|<details><summary>pass</summary>[Hu2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000744#Files)</details>|pass|pass|
|[BIOMD0000000745](https://www.ebi.ac.uk/biomodels/BIOMD0000000745)<br/><sup>Jarrett2018 - trastuzumab-induced immune response in murine HER2+ breast cancer model</sup>|<details><summary>pass</summary>[Jarrett2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000745#Files)</details>|FAIL|<details><summary>pass</summary>[Jarrett2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000745#Files)</details>|pass|pass|
|[BIOMD0000000746](https://www.ebi.ac.uk/biomodels/BIOMD0000000746)<br/><sup>Saad2017 - immune checkpoint and BCG in superficial bladder cancer</sup>|<details><summary>pass</summary>[Saad2017.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000746#Files)</details>|FAIL|<details><summary>pass</summary>[Saad2017.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000746#Files)</details>|pass|pass|
|[BIOMD0000000747](https://www.ebi.ac.uk/biomodels/BIOMD0000000747)<br/><sup>Nagashima2002 - Simulating blood coagulation inhibitory effects</sup>|<details><summary>pass</summary>[Nagashima2002.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000747#Files)</details>|pass|<details><summary>pass</summary>[Nagashima2002.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000747#Files)</details>|pass|pass|
|[BIOMD0000000748](https://www.ebi.ac.uk/biomodels/BIOMD0000000748)<br/><sup>Phan2017 - innate immune in oncolytic virotherapy</sup>|<details><summary>pass</summary>[Phan2017.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000748#Files)</details>|FAIL|<details><summary>pass</summary>[Phan2017.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000748#Files)</details>|pass|pass|
|[BIOMD0000000749](https://www.ebi.ac.uk/biomodels/BIOMD0000000749)<br/><sup>Reppas2015 - tumor control via alternating immunostimulating and immunosuppressive phases</sup>|<details><summary>pass</summary>[Reppas2015.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000749#Files)</details>|FAIL|<details><summary>pass</summary>[Reppas2015.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000749#Files)</details>|pass|pass|
|[BIOMD0000000750](https://www.ebi.ac.uk/biomodels/BIOMD0000000750)<br/><sup>Lolas2016 - tumour-induced neoneurogenesis and perineural tumour growth</sup>|<details><summary>pass</summary>[Lolas2016.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000750#Files)</details>|FAIL|<details><summary>pass</summary>[Lolas2016.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000750#Files)</details>|pass|pass|
|[BIOMD0000000751](https://www.ebi.ac.uk/biomodels/BIOMD0000000751)<br/><sup>Wilkie2013b - immune-induced cancer dormancy and immune evasion-basic</sup>|<details><summary>pass</summary>[Wilkie2013b.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000751#Files)</details>|FAIL|<details><summary>pass</summary>[Wilkie2013b.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000751#Files)</details>|pass|pass|
|[BIOMD0000000752](https://www.ebi.ac.uk/biomodels/BIOMD0000000752)<br/><sup>Wilkie2013r - immune-induced cancer dormancy and immune evasion-resistance</sup>|<details><summary>pass</summary>[Wilkie2013r.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000752#Files)</details>|FAIL|<details><summary>pass</summary>[Wilkie2013r.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000752#Files)</details>|pass|pass|
|[BIOMD0000000753](https://www.ebi.ac.uk/biomodels/BIOMD0000000753)<br/><sup>Figueredo2013/1 - immunointeraction base model</sup>|<details><summary>pass</summary>[Figueredo2013:1.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000753#Files)</details>|FAIL|<details><summary>pass</summary>[Figueredo2013:1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000753#Files)</details>|pass|pass|
|[BIOMD0000000754](https://www.ebi.ac.uk/biomodels/BIOMD0000000754)<br/><sup>Figueredo2013/2 - immunointeraction model with IL2</sup>|<details><summary>pass</summary>[Figueredo2013:2.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000754#Files)</details>|FAIL|<details><summary>pass</summary>[Figueredo2013:2.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000754#Files)</details>|pass|pass|
|[BIOMD0000000755](https://www.ebi.ac.uk/biomodels/BIOMD0000000755)<br/><sup>Hansen2019 - Nine species reduced model of blood coagulation</sup>|<details><summary>pass</summary>[Hansen2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000755#Files)</details>|pass|<details><summary>FAIL</summary>[Hansen2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000755#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Hansen2019.sedml```</details>|
|[BIOMD0000000756](https://www.ebi.ac.uk/biomodels/BIOMD0000000756)<br/><sup>Figueredo2013/3 - immunointeraction full model</sup>|<details><summary>pass</summary>[Figueredo2013:3.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000756#Files)</details>|FAIL|<details><summary>pass</summary>[Figueredo2013:3.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000756#Files)</details>|pass|pass|
|[BIOMD0000000757](https://www.ebi.ac.uk/biomodels/BIOMD0000000757)<br/><sup>Abernathy2016 - glioblastoma treatment</sup>|<details><summary>pass</summary>[Abernathy2016.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000757#Files)</details>|FAIL|<details><summary>pass</summary>[Abernathy2016.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000757#Files)</details>|pass|pass|
|[BIOMD0000000758](https://www.ebi.ac.uk/biomodels/BIOMD0000000758)<br/><sup>Babbs2012 - immunotherapy</sup>|<details><summary>pass</summary>[Babbs2012.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000758#Files)</details>|FAIL|<details><summary>pass</summary>[Babbs2012.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000758#Files)</details>|pass|pass|
|[BIOMD0000000759](https://www.ebi.ac.uk/biomodels/BIOMD0000000759)<br/><sup>den Breems2015 - macrophage in cancer</sup>|<details><summary>pass</summary>[denBreems2015.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000759#Files)</details>|FAIL|<details><summary>pass</summary>[denBreems2015.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000759#Files)</details>|pass|pass|
|[BIOMD0000000760](https://www.ebi.ac.uk/biomodels/BIOMD0000000760)<br/><sup>Feizabadi2011/1 - immunodeficiency in cancer core model</sup>|<details><summary>pass</summary>[Feizabadi2011_1.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000760#Files)</details>|FAIL|<details><summary>pass</summary>[Feizabadi2011_1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000760#Files)</details>|pass|pass|
|[BIOMD0000000761](https://www.ebi.ac.uk/biomodels/BIOMD0000000761)<br/><sup>Cappuccio2006 - Cancer immunotherapy by interleukin-21</sup>|<details><summary>pass</summary>[Cappuccio2006 v2.0.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000761#Files)</details>|FAIL|<details><summary>pass</summary>[Cappuccio2006 v9.0.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000761#Files)</details>|pass|pass|
|[BIOMD0000000762](https://www.ebi.ac.uk/biomodels/BIOMD0000000762)<br/><sup>Kuznetsov1994 - Nonlinear dynamics of immunogenic tumors</sup>|<details><summary>pass</summary>[Kuznetsov1994.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000762#Files)</details>|pass|<details><summary>pass</summary>[Kuznetsov1994.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000762#Files)</details>|pass|pass|
|[BIOMD0000000763](https://www.ebi.ac.uk/biomodels/BIOMD0000000763)<br/><sup>Dritschel2018 - A mathematical model of cytotoxic and helper T cell interactions in a tumour microenvironment</sup>|<details><summary>pass</summary>[Dritschel2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000763#Files)</details>|FAIL|<details><summary>pass</summary>[Dritschel2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000763#Files)</details>|pass|pass|
|[BIOMD0000000764](https://www.ebi.ac.uk/biomodels/BIOMD0000000764)<br/><sup>Malinzi2019 - chemovirotherapy</sup>|<details><summary>pass</summary>[Malinzi2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000764#Files)</details>|FAIL|<details><summary>pass</summary>[Malinzi2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000764#Files)</details>|pass|pass|
|[BIOMD0000000765](https://www.ebi.ac.uk/biomodels/BIOMD0000000765)<br/><sup>Mager2005 - Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition</sup>|<details><summary>pass</summary>[Mager2005.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000765#Files)</details>|pass|<details><summary>pass</summary>[Mager2005.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000765#Files)</details>|pass|pass|
|[BIOMD0000000766](https://www.ebi.ac.uk/biomodels/BIOMD0000000766)<br/><sup>Macnamara2015/1 - virotherapy full model</sup>|<details><summary>pass</summary>[Macnamara2015:1.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000766#Files)</details>|FAIL|<details><summary>pass</summary>[Macnamara2015:1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000766#Files)</details>|pass|pass|
|[BIOMD0000000767](https://www.ebi.ac.uk/biomodels/BIOMD0000000767)<br/><sup>Macnamara2015/2 - virotherapy virus-free submodel</sup>|<details><summary>pass</summary>[Macnamara2015:2.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000767#Files)</details>|FAIL|<details><summary>pass</summary>[Macnamara2015:2.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000767#Files)</details>|pass|pass|
|[BIOMD0000000768](https://www.ebi.ac.uk/biomodels/BIOMD0000000768)<br/><sup>Eftimie2010 - immunity to melanoma</sup>|<details><summary>pass</summary>[Eftimie2010.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000768#Files)</details>|FAIL|<details><summary>pass</summary>[Eftimie2010.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000768#Files)</details>|pass|pass|
|[BIOMD0000000769](https://www.ebi.ac.uk/biomodels/BIOMD0000000769)<br/><sup>Eftimie2017/2 - interaction of Th and macrophage in melanoma</sup>|<details><summary>pass</summary>[Eftimie2017:2.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000769#Files)</details>|FAIL|<details><summary>pass</summary>[Eftimie2017:2.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000769#Files)</details>|pass|pass|
|[BIOMD0000000770](https://www.ebi.ac.uk/biomodels/BIOMD0000000770)<br/><sup>Eftimie2017/1 - interaction of Th and macrophage</sup>|<details><summary>pass</summary>[Eftimie2017:1.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000770#Files)</details>|FAIL|<details><summary>pass</summary>[Eftimie2017:1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000770#Files)</details>|pass|pass|
|[BIOMD0000000771](https://www.ebi.ac.uk/biomodels/BIOMD0000000771)<br/><sup>Bajzer2008 - Modeling of cancer virotherapy with recombinant measles viruses</sup>|<details><summary>pass</summary>[Bazjer2008.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000771#Files)</details>|FAIL|<details><summary>pass</summary>[Bazjer2008.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000771#Files)</details>|pass|pass|
|[BIOMD0000000772](https://www.ebi.ac.uk/biomodels/BIOMD0000000772)<br/><sup>Wang2019 - A mathematical model of oncolytic virotherapy with time delay</sup>|<details><summary>pass</summary>[Wang2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000772#Files)</details>|pass|<details><summary>pass</summary>[Wang2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000772#Files)</details>|pass|pass|
|[BIOMD0000000773](https://www.ebi.ac.uk/biomodels/BIOMD0000000773)<br/><sup>Wodarz2018/2 - model with transit amplifying cells</sup>|<details><summary>pass</summary>[Wodarz2018:2.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000773#Files)</details>|FAIL|<details><summary>pass</summary>[Wodarz2018:2.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000773#Files)</details>|pass|pass|
|[BIOMD0000000774](https://www.ebi.ac.uk/biomodels/BIOMD0000000774)<br/><sup>Wodarz2018/1 - simple model</sup>|<details><summary>pass</summary>[Wodarz2018:1.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000774#Files)</details>|FAIL|<details><summary>pass</summary>[Wodarz2018:1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000774#Files)</details>|pass|pass|
|[BIOMD0000000775](https://www.ebi.ac.uk/biomodels/BIOMD0000000775)<br/><sup>Iarosz2015 - brain tumor</sup>|<details><summary>pass</summary>[Iarosz2015.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000775#Files)</details>|FAIL|<details><summary>pass</summary>[Iarosz2015.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000775#Files)</details>|pass|<details><summary>FAIL (CV_CONV_FAILURE)</summary>```CVODE Error: CV_CONV_FAILURE: Convergence test failures occurred too many times (= MXNCF = 10) during one internal timestep or occurred with |h| = hmin.; In virtual double rr::CVODEIntegrator::integrate(double, double)```</details>|
|[BIOMD0000000776](https://www.ebi.ac.uk/biomodels/BIOMD0000000776)<br/><sup>Monro2008 - chemotherapy resistance</sup>|<details><summary>pass</summary>[Monro2008.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000776#Files)</details>|FAIL|<details><summary>pass</summary>[Monro2008.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000776#Files)</details>|pass|pass|
|[BIOMD0000000777](https://www.ebi.ac.uk/biomodels/BIOMD0000000777)<br/><sup>Chakrabarty2010 - A control theory approach to cancer remission aided by an optimal therapy</sup>|<details><summary>pass</summary>[Chakrabarty2010.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000777#Files)</details>|pass|<details><summary>FAIL</summary>[Chakrabarty2010.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000777#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Chakrabarty2010.sedml```</details>|
|[BIOMD0000000778](https://www.ebi.ac.uk/biomodels/BIOMD0000000778)<br/><sup>Wei2017 - tumor, T cell and cytokine interaction</sup>|<details><summary>pass</summary>[Wei2017.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000778#Files)</details>|FAIL|<details><summary>pass</summary>[Wei2017.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000778#Files)</details>|pass|pass|
|[BIOMD0000000779](https://www.ebi.ac.uk/biomodels/BIOMD0000000779)<br/><sup>dePillis2009 - Mathematical model creation for cancer chemo-immunotherapy</sup>|<details><summary>pass</summary>[dePillis2009.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000779#Files)</details>|pass|<details><summary>pass</summary>[dePillis2009.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000779#Files)</details>|pass|pass|
|[BIOMD0000000780](https://www.ebi.ac.uk/biomodels/BIOMD0000000780)<br/><sup>Wang2016/1 - oncolytic efficacy of M1 virus-SNTM model</sup>|<details><summary>pass</summary>[Wang2016:1.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000780#Files)</details>|FAIL|<details><summary>pass</summary>[Wang2016:1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000780#Files)</details>|pass|pass|
|[BIOMD0000000781](https://www.ebi.ac.uk/biomodels/BIOMD0000000781)<br/><sup>Wang2016/2 - oncolytic efficacy of M1 virus-SNT model</sup>|<details><summary>pass</summary>[Wang2016:2.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000781#Files)</details>|FAIL|<details><summary>pass</summary>[Wang2016:2.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000781#Files)</details>|pass|pass|
|[BIOMD0000000782](https://www.ebi.ac.uk/biomodels/BIOMD0000000782)<br/><sup>Wang2016/3 - oncolytic efficacy of M1 virus-SN model</sup>|<details><summary>pass</summary>[Wang2016:3.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000782#Files)</details>|FAIL|<details><summary>pass</summary>[Wang2016:3.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000782#Files)</details>|pass|pass|
|[BIOMD0000000783](https://www.ebi.ac.uk/biomodels/BIOMD0000000783)<br/><sup>Dong2014 - Mathematical modeling on helper t cells in a tumor immune system</sup>|<details><summary>pass</summary>[Dong2014.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000783#Files)</details>|FAIL|<details><summary>pass</summary>[Dong2014.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000783#Files)</details>|pass|pass|
|[BIOMD0000000784](https://www.ebi.ac.uk/biomodels/BIOMD0000000784)<br/><sup>Lopez2014 - A Validated Mathematical Model of Tumor Growth Including Tumor-Host Interaction and Cell-Mediated Immune Response</sup>|<details><summary>pass</summary>[Lopez2014.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000784#Files)</details>|FAIL|<details><summary>pass</summary>[Lopez2014.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000784#Files)</details>|pass|pass|
|[BIOMD0000000785](https://www.ebi.ac.uk/biomodels/BIOMD0000000785)<br/><sup>Sotolongo-Costa2003 - Behavior of tumors under nonstationary therapy</sup>|<details><summary>pass</summary>[Sotolongo-Costa2003.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000785#Files)</details>|FAIL|<details><summary>pass</summary>[Sotolongo-Costa2003.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000785#Files)</details>|pass|pass|
|[BIOMD0000000786](https://www.ebi.ac.uk/biomodels/BIOMD0000000786)<br/><sup>Lipniacki2004 - Mathematical model of NFKB regulatory module</sup>|<details><summary>FAIL</summary>[Lipniacki2004.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000786#Files)</details>|FAIL|<details><summary>pass</summary>[Lipniacki2004.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000786#Files)</details>|pass|pass|
|[BIOMD0000000787](https://www.ebi.ac.uk/biomodels/BIOMD0000000787)<br/><sup>Frascoli2014 - A dynamical model of tumour immunotherapy</sup>|<details><summary>pass</summary>[Frascoli2014.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000787#Files)</details>|FAIL|<details><summary>pass</summary>[Frascoli2014.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000787#Files)</details>|pass|pass|
|[BIOMD0000000788](https://www.ebi.ac.uk/biomodels/BIOMD0000000788)<br/><sup>Schropp2019 - Target-Mediated Drug Disposition Model for Bispecific Antibodies</sup>|<details><summary>pass</summary>[Schropp2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000788#Files)</details>|FAIL|<details><summary>pass</summary>[Schropp2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000788#Files)</details>|pass|pass|
|[BIOMD0000000789](https://www.ebi.ac.uk/biomodels/BIOMD0000000789)<br/><sup>Jenner2018 - treatment of oncolytic virus</sup>|<details><summary>pass</summary>[Jenner2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000789#Files)</details>|FAIL|<details><summary>pass</summary>[Jenner2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000789#Files)</details>|pass|pass|
|[BIOMD0000000790](https://www.ebi.ac.uk/biomodels/BIOMD0000000790)<br/><sup>Alvarez2019 - A nonlinear mathematical model of cell-mediated immune response for tumor phenotypic heterogeneity</sup>|<details><summary>pass</summary>[Alvarez2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000790#Files)</details>|pass|<details><summary>pass</summary>[Alvarez2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000790#Files)</details>|pass|pass|
|[BIOMD0000000791](https://www.ebi.ac.uk/biomodels/BIOMD0000000791)<br/><sup>Wilson2012 - tumor vaccine efficacy</sup>|<details><summary>pass</summary>[Wilson2012.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000791#Files)</details>|FAIL|<details><summary>pass</summary>[Wilson2012.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000791#Files)</details>|pass|pass|
|[BIOMD0000000792](https://www.ebi.ac.uk/biomodels/BIOMD0000000792)<br/><sup>Hu2019 - Modeling Pancreatic Cancer Dynamics with Immunotherapy</sup>|<details><summary>pass</summary>[Hu2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000792#Files)</details>|pass|<details><summary>pass</summary>[Hu2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000792#Files)</details>|pass|pass|
|[BIOMD0000000794](https://www.ebi.ac.uk/biomodels/BIOMD0000000794)<br/><sup>Benary2019 - Controlling NFKB dynamics by B-TrCP</sup>|<details><summary>FAIL</summary>[Benary2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000794#Files)</details>|FAIL|<details><summary>pass</summary>[Benary2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000794#Files)</details>|pass|pass|
|[BIOMD0000000795](https://www.ebi.ac.uk/biomodels/BIOMD0000000795)<br/><sup>Chen2011/2 - bone marrow invasion relative model</sup>|<details><summary>pass</summary>[Chen2011:2.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000795#Files)</details>|FAIL|<details><summary>pass</summary>[Chen2011:2.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000795#Files)</details>|pass|pass|
|[BIOMD0000000796](https://www.ebi.ac.uk/biomodels/BIOMD0000000796)<br/><sup>Yang2012 - cancer growth with angiogenesis</sup>|<details><summary>pass</summary>[Yang2012.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000796#Files)</details>|FAIL|<details><summary>pass</summary>[Yang2012.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000796#Files)</details>|pass|pass|
|[BIOMD0000000797](https://www.ebi.ac.uk/biomodels/BIOMD0000000797)<br/><sup>Hu2018 - Dynamics of tumor-CD4+-cytokine-host cells interactions with treatments</sup>|<details><summary>pass</summary>[Hu2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000797#Files)</details>|pass|<details><summary>pass</summary>[Hu2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000797#Files)</details>|pass|pass|
|[BIOMD0000000798](https://www.ebi.ac.uk/biomodels/BIOMD0000000798)<br/><sup>Sharp2019 - AML</sup>|<details><summary>pass</summary>[Sharp2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000798#Files)</details>|FAIL|<details><summary>pass</summary>[Sharp2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000798#Files)</details>|pass|pass|
|[BIOMD0000000799](https://www.ebi.ac.uk/biomodels/BIOMD0000000799)<br/><sup>Cucuianu2010 - A hypothetical-mathematical model of acute myeloid leukaemia pathogenesis</sup>|<details><summary>pass</summary>[Cucuianu2010.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000799#Files)</details>|pass|<details><summary>FAIL</summary>[Cucuianu2010.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000799#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Cucuianu2010.sedml```</details>|
|[BIOMD0000000800](https://www.ebi.ac.uk/biomodels/BIOMD0000000800)<br/><sup>Precup2012 - Mathematical modeling of cell dynamics after allogeneic bone marrow transplantation</sup>|<details><summary>pass</summary>[Precup2012.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000800#Files)</details>|pass|<details><summary>pass</summary>[Precup2012.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000800#Files)</details>|pass|pass|
|[BIOMD0000000801](https://www.ebi.ac.uk/biomodels/BIOMD0000000801)<br/><sup>Sturrock2015 - glioma growth</sup>|<details><summary>pass</summary>[Sturrock2015.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000801#Files)</details>|FAIL|<details><summary>pass</summary>[Sturrock2015.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000801#Files)</details>|pass|pass|
|[BIOMD0000000802](https://www.ebi.ac.uk/biomodels/BIOMD0000000802)<br/><sup>Hoffman2018- ADCC against cancer</sup>|<details><summary>pass</summary>[Hoffman2017.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000802#Files)</details>|FAIL|<details><summary>pass</summary>[Hoffman2017.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000802#Files)</details>|pass|pass|
|[BIOMD0000000803](https://www.ebi.ac.uk/biomodels/BIOMD0000000803)<br/><sup>Park2019 - IL7 receptor signaling in T cells</sup>|<details><summary>pass</summary>[Park2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000803#Files)</details>|pass|<details><summary>pass</summary>[Park2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000803#Files)</details>|pass|pass|
|[BIOMD0000000804](https://www.ebi.ac.uk/biomodels/BIOMD0000000804)<br/><sup>Koenders2015 - multiple myeloma</sup>|<details><summary>pass</summary>[Koenders2015.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000804#Files)</details>|FAIL|<details><summary>pass</summary>[Koenders2015.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000804#Files)</details>|pass|pass|
|[BIOMD0000000805](https://www.ebi.ac.uk/biomodels/BIOMD0000000805)<br/><sup>Al-Husari2013 - pH and lactate in tumor</sup>|<details><summary>pass</summary>[Al-Husari2013.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000805#Files)</details>|FAIL|<details><summary>pass</summary>[Al-Husari2013.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000805#Files)</details>|pass|pass|
|[BIOMD0000000807](https://www.ebi.ac.uk/biomodels/BIOMD0000000807)<br/><sup>Fassoni2019 - Oncogenesis encompassing mutations and genetic instability</sup>|<details><summary>pass</summary>[model.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000807#Files)</details>|FAIL|<details><summary>pass</summary>[Fassoni2019 - 5A.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000807#Files)</details>|FAIL|pass|
|[BIOMD0000000808](https://www.ebi.ac.uk/biomodels/BIOMD0000000808)<br/><sup>Kronik2008 - Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics</sup>|<details><summary>pass</summary>[Kronik2008.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000808#Files)</details>|pass|<details><summary>pass</summary>[Kronik2008.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000808#Files)</details>|pass|pass|
|[BIOMD0000000809](https://www.ebi.ac.uk/biomodels/BIOMD0000000809)<br/><sup>Malinzi2018 - tumour-immune interaction model</sup>|<details><summary>pass</summary>[Malinzi2018 - tumour-immune interaction model.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000809#Files)</details>|pass|<details><summary>FAIL</summary>[Malinzi2018 - tumour-immune interaction model.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000809#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Malinzi2018 - tumour-immune interaction model.sedml```</details>|
|[BIOMD0000000810](https://www.ebi.ac.uk/biomodels/BIOMD0000000810)<br/><sup>Ganguli2018-immuno regulatory mechanisms in tumor microenvironment</sup>|<details><summary>pass</summary>[Ganguli2018-immuno regulatory mechanisms in tumor microenvironment.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000810#Files)</details>|FAIL|<details><summary>FAIL</summary>[Ganguli2018-immuno regulatory mechanisms in tumor microenvironment.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000810#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Ganguli2018-immuno regulatory mechanisms in tumor microenvironment.sedml```</details>|
|[BIOMD0000000811](https://www.ebi.ac.uk/biomodels/BIOMD0000000811)<br/><sup>He2017 - A mathematical model of pancreatic cancer with two kinds of treatments</sup>|<details><summary>pass</summary>[He2017.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000811#Files)</details>|pass|<details><summary>pass</summary>[He2017.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000811#Files)</details>|pass|pass|
|[BIOMD0000000812](https://www.ebi.ac.uk/biomodels/BIOMD0000000812)<br/><sup>Galante2012 - B7-H1 and a Mathematical Model for Cytotoxic T Cell and Tumor Cell Interaction</sup>|<details><summary>pass</summary>[Galante2012.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000812#Files)</details>|pass|<details><summary>pass</summary>[Galante2012.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000812#Files)</details>|pass|pass|
|[BIOMD0000000813](https://www.ebi.ac.uk/biomodels/BIOMD0000000813)<br/><sup>Anderson2015 - Qualitative behavior of systems of tumor-CD4+-cytokine interactions with treatments</sup>|<details><summary>pass</summary>[Anderson2015.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000813#Files)</details>|pass|<details><summary>pass</summary>[Anderson2015.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000813#Files)</details>|pass|pass|
|[BIOMD0000000814](https://www.ebi.ac.uk/biomodels/BIOMD0000000814)<br/><sup>Perez-Garcia19 - Computational design of improved standardized chemotherapy protocols for grade 2 oligodendrogliomas</sup>|<details><summary>pass</summary>[Perez-Garcia19 Computational design of improved standardized chemotherapy protocols for grade 2 oligodendrogliomas.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000814#Files)</details>|FAIL|<details><summary>FAIL</summary>[Perez-Garcia19 Computational design of improved standardized chemotherapy protocols for grade 2 oligodendrogliomas.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000814#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Perez-Garcia19 Computational design of improved standardized chemotherapy protocols for grade 2 oligodendrogliomas.sedml```</details>|
|[BIOMD0000000815](https://www.ebi.ac.uk/biomodels/BIOMD0000000815)<br/><sup>Chrobak2011 - A mathematical model of induced cancer-adaptive immune system competition</sup>|<details><summary>pass</summary>[Chrobak2011.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000815#Files)</details>|pass|<details><summary>pass</summary>[Chrobak2011.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000815#Files)</details>|pass|pass|
|[BIOMD0000000818](https://www.ebi.ac.uk/biomodels/BIOMD0000000818)<br/><sup>Lee2008 - ERK and PI3K signal integration by Myc</sup>|<details><summary>pass</summary>[Lee2008.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000818#Files)</details>|pass|<details><summary>pass</summary>[Lee2008.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000818#Files)</details>|pass|pass|
|[BIOMD0000000823](https://www.ebi.ac.uk/biomodels/BIOMD0000000823)<br/><sup>Varusai2018 - Dynamic modelling of the mTOR signalling network reveals complex emergent behaviours conferred by DEPTOR</sup>|<details><summary>pass</summary>[Varusai2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000823#Files)</details>|pass|<details><summary>pass</summary>[Varusai2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000823#Files)</details>|pass|pass|
|[BIOMD0000000825](https://www.ebi.ac.uk/biomodels/BIOMD0000000825)<br/><sup>Greene2019 - Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer Treatment</sup>|<details><summary>pass</summary>[Greene2019 - Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer Treatment.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000825#Files)</details>|pass|<details><summary>FAIL</summary>[Greene2019 - Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer Treatment.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000825#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Greene2019 - Differentiate Spontaneous and Induced Evolution to Drug Resistance During Cancer Treatment.sedml```</details>|
|[BIOMD0000000826](https://www.ebi.ac.uk/biomodels/BIOMD0000000826)<br/><sup>Shin_2018_EGFR-PYK2-c-Met interaction network_model</sup>|<details><summary>pass</summary>[Shin2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000826#Files)</details>|pass|<details><summary>pass</summary>[Shin2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000826#Files)</details>|pass|pass|
|[BIOMD0000000828](https://www.ebi.ac.uk/biomodels/BIOMD0000000828)<br/><sup>Jung2019 - Regulating glioblastoma signaling pathways and anti-invasion therapy - core control model</sup>|<details><summary>pass</summary>[Jung2019 model.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000828#Files)</details>|FAIL|<details><summary>pass</summary>[Jung2019 simulation.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000828#Files)</details>|FAIL|pass|
|[BIOMD0000000830](https://www.ebi.ac.uk/biomodels/BIOMD0000000830)<br/><sup>GiantsosAdams2013 - Growth of glycocalyx under static conditions</sup>|<details><summary>FAIL</summary>[Giantsos-Adams2013.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000830#Files)</details>|FAIL|<details><summary>pass</summary>[Giantsos-Adams2013.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000830#Files)</details>|pass|pass|
|[BIOMD0000000831](https://www.ebi.ac.uk/biomodels/BIOMD0000000831)<br/><sup>Smith1980 - Hypothalamic Regulation</sup>|<details><summary>pass</summary>[Smith1980_HypothalamicRegulation.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000831#Files)</details>|FAIL|<details><summary>FAIL</summary>[Smith1980_HypothalamicRegulation.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000831#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Smith1980_HypothalamicRegulation.sedml```</details>|
|[BIOMD0000000832](https://www.ebi.ac.uk/biomodels/BIOMD0000000832)<br/><sup>Shin2016 - Unveiling Hidden Dynamics of Hippo Signalling</sup>|<details><summary>pass</summary>[Shin2016.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000832#Files)</details>|pass|<details><summary>pass</summary>[Shin2016.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000832#Files)</details>|pass|pass|
|[BIOMD0000000833](https://www.ebi.ac.uk/biomodels/BIOMD0000000833)<br/><sup>DiCamillo2016 - Insulin signalling pathway - Rule-based model</sup>|<details><summary>pass</summary>[DiCamillo2016.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000833#Files)</details>|pass|<details><summary>pass</summary>[DiCamillo2016.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000833#Files)</details>|pass|pass|
|[BIOMD0000000834](https://www.ebi.ac.uk/biomodels/BIOMD0000000834)<br/><sup>Verma2016 - Ca(2+) Signal Propagation Along Hepatocyte Cords</sup>|<details><summary>pass</summary>[Verma2016.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000834#Files)</details>|pass|<details><summary>pass</summary>[Verma2016.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000834#Files)</details>|pass|pass|
|[BIOMD0000000835](https://www.ebi.ac.uk/biomodels/BIOMD0000000835)<br/><sup>Rao2014 - Fatty acid beta-oxidation (reduced model)</sup>|<details><summary>pass</summary>[Rao2014.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000835#Files)</details>|pass|<details><summary>pass</summary>[Rao2014.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000835#Files)</details>|pass|pass|
|[BIOMD0000000836](https://www.ebi.ac.uk/biomodels/BIOMD0000000836)<br/><sup>Radosavljevic2009_BioterroristAttack_PanicProtection_1</sup>|<details><summary>pass</summary>[Radosavljevic2009.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000836#Files)</details>|pass|<details><summary>pass</summary>[Radosavljevic2009.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000836#Files)</details>|pass|pass|
|[BIOMD0000000837](https://www.ebi.ac.uk/biomodels/BIOMD0000000837)<br/><sup>Hanson2016 - Toxicity Management in CAR T cell therapy for B-ALL</sup>|<details><summary>pass</summary>[Hanson2016.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000837#Files)</details>|FAIL|<details><summary>pass</summary>[Hanson2016.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000837#Files)</details>|pass|pass|
|[BIOMD0000000838](https://www.ebi.ac.uk/biomodels/BIOMD0000000838)<br/><sup>Tsur2019 - Response of patients with melanoma to immune checkpoint blockade</sup>|<details><summary>pass</summary>[Tsur2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000838#Files)</details>|pass|<details><summary>pass</summary>[Tsur2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000838#Files)</details>|pass|pass|
|[BIOMD0000000839](https://www.ebi.ac.uk/biomodels/BIOMD0000000839)<br/><sup>Almeida2019 - Transcription-based circadian mechanism controls the duration of molecular clock states in response to signaling inputs</sup>|<details><summary>pass</summary>[Almeida2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000839#Files)</details>|pass|<details><summary>pass</summary>[Almeida2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000839#Files)</details>|pass|pass|
|[BIOMD0000000840](https://www.ebi.ac.uk/biomodels/BIOMD0000000840)<br/><sup>Caldwell2019 - The Vicodin abuse problem</sup>|<details><summary>pass</summary>[Caldwell2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000840#Files)</details>|pass|<details><summary>pass</summary>[Caldwell2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000840#Files)</details>|pass|pass|
|[BIOMD0000000842](https://www.ebi.ac.uk/biomodels/BIOMD0000000842)<br/><sup>Heitzler2012 - GPCR signalling</sup>|<details><summary>pass</summary>[MODEL1012080000.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000842#Files)</details>|pass|<details><summary>pass</summary>[MODEL1012080000.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000842#Files)</details>|pass|pass|
|[BIOMD0000000843](https://www.ebi.ac.uk/biomodels/BIOMD0000000843)<br/><sup>Dudziuk2019 - Biologically sound formal model of Hsp70 heat induction</sup>|<details><summary>pass</summary>[Dudziuk2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000843#Files)</details>|pass|<details><summary>pass</summary>[Dudziuk2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000843#Files)</details>|pass|pass|
|[BIOMD0000000844](https://www.ebi.ac.uk/biomodels/BIOMD0000000844)<br/><sup>Viertel2019 - A Computational model of the mammalian external tufted cell</sup>|<details><summary>pass</summary>[Viertel2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000844#Files)</details>|pass|<details><summary>pass</summary>[Viertel2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000844#Files)</details>|pass|pass|
|[BIOMD0000000845](https://www.ebi.ac.uk/biomodels/BIOMD0000000845)<br/><sup>Gulbudak2019.1 - Heterogeneous viral strategies promote coexistence in virus-microbe systems (Lytic)</sup>|<details><summary>pass</summary>[Gulbudak2019.1.Lytic.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000845#Files)</details>|pass|<details><summary>pass</summary>[Gulbudak2019.1.Lytic.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000845#Files)</details>|pass|pass|
|[BIOMD0000000846](https://www.ebi.ac.uk/biomodels/BIOMD0000000846)<br/><sup>Gulbudak2019.2 - Heterogeneous viral strategies promote coexistence in virus-microbe systems (Chronic)</sup>|<details><summary>pass</summary>[Gulbudak2019.2.Chronic.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000846#Files)</details>|pass|<details><summary>FAIL</summary>[Gulbudak2019.2.Chronic.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000846#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Gulbudak2019.2.Chronic.sedml```</details>|
|[BIOMD0000000847](https://www.ebi.ac.uk/biomodels/BIOMD0000000847)<br/><sup>Adams2019 - The regulatory role of shikimate in plant phenylalanine metabolism</sup>|<details><summary>pass</summary>[Adams2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000847#Files)</details>|pass|<details><summary>pass</summary>[Adams2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000847#Files)</details>|pass|pass|
|[BIOMD0000000848](https://www.ebi.ac.uk/biomodels/BIOMD0000000848)<br/><sup>FatehiChenar2018 - Mathematical model of immune response to hepatitis B</sup>|<details><summary>pass</summary>[FatehiChenar2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000848#Files)</details>|pass|<details><summary>pass</summary>[FatehiChenar2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000848#Files)</details>|pass|pass|
|[BIOMD0000000849](https://www.ebi.ac.uk/biomodels/BIOMD0000000849)<br/><sup>Potassium balance in lactating and non-lactating dairy cows</sup>|<details><summary>FAIL</summary>[Berg2017.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000849#Files)</details>|FAIL|<details><summary>pass</summary>[Berg2017.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000849#Files)</details>|pass|pass|
|[BIOMD0000000850](https://www.ebi.ac.uk/biomodels/BIOMD0000000850)<br/><sup>Jenner2019 - Oncolytic virotherapy for tumours following a Gompertz growth law</sup>|<details><summary>pass</summary>[Jenner2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000850#Files)</details>|FAIL|<details><summary>pass</summary>[Jenner2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000850#Files)</details>|pass|pass|
|[BIOMD0000000851](https://www.ebi.ac.uk/biomodels/BIOMD0000000851)<br/><sup>Ho2019 - Mathematical models of transmission dynamics and vaccine strategies in Hong Kong during the 2017-2018 winter influenza season (Simple)</sup>|<details><summary>pass</summary>[Ho2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000851#Files)</details>|pass|<details><summary>pass</summary>[Ho2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000851#Files)</details>|pass|pass|
|[BIOMD0000000852](https://www.ebi.ac.uk/biomodels/BIOMD0000000852)<br/><sup>Andersen2017 - Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development</sup>|<details><summary>pass</summary>[Andersen2017.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000852#Files)</details>|pass|<details><summary>pass</summary>[Andersen2017.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000852#Files)</details>|pass|pass|
|[BIOMD0000000853](https://www.ebi.ac.uk/biomodels/BIOMD0000000853)<br/><sup>Smolen2018 - Paradoxical LTP maintenance with inhibition of protein synthesis and the proteasome</sup>|<details><summary>pass</summary>[Smolen2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000853#Files)</details>|pass|<details><summary>pass</summary>[Smolen2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000853#Files)</details>|pass|pass|
|[BIOMD0000000854](https://www.ebi.ac.uk/biomodels/BIOMD0000000854)<br/><sup>Gray2016 - The Akt switch model</sup>|<details><summary>pass</summary>[Gray2016.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000854#Files)</details>|pass|<details><summary>pass</summary>[Gray2016.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000854#Files)</details>|pass|pass|
|[BIOMD0000000855](https://www.ebi.ac.uk/biomodels/BIOMD0000000855)<br/><sup>Cooper2015 - Modeling the effects of systemic mediators on the inflammatory phase of wound healing</sup>|<details><summary>pass</summary>[Cooper2015.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000855#Files)</details>|pass|<details><summary>pass</summary>[Cooper2015.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000855#Files)</details>|pass|pass|
|[BIOMD0000000856](https://www.ebi.ac.uk/biomodels/BIOMD0000000856)<br/><sup>Budding yeast size control by titration of nuclear sites</sup>|<details><summary>pass</summary>[Heldt2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000856#Files)</details>|FAIL|<details><summary>pass</summary>[Heldt2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000856#Files)</details>|pass|pass|
|[BIOMD0000000857](https://www.ebi.ac.uk/biomodels/BIOMD0000000857)<br/><sup>Larbat2016.1 - Modeling the diversion of primary carbon flux into secondary metabolism under variable nitrate and light or dark conditions (Base Model)</sup>|<details><summary>pass</summary>[Larbat2016.1.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000857#Files)</details>|pass|<details><summary>pass</summary>[Larbat2016.1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000857#Files)</details>|pass|pass|
|[BIOMD0000000858](https://www.ebi.ac.uk/biomodels/BIOMD0000000858)<br/><sup>Larbat2016.2 - Modeling the diversion of primary carbon flux into secondary metabolism under variable nitrate and light or dark conditions (Light Dark Cycles)</sup>|<details><summary>pass</summary>[Larbat2016.2.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000858#Files)</details>|pass|<details><summary>FAIL</summary>[Larbat2016.2.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000858#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Larbat2016.2.sedml```</details>|
|[BIOMD0000000859](https://www.ebi.ac.uk/biomodels/BIOMD0000000859)<br/><sup>Larbat2016.3 - Modeling the diversion of primary carbon flux into secondary metabolism under variable nitrate and light or dark conditions (Light Dark Cycles with Minimum Starch Adaption)</sup>|<details><summary>pass</summary>[Larbat2016.3.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000859#Files)</details>|pass|<details><summary>FAIL</summary>[Larbat2016.3.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000859#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Larbat2016.3.sedml```</details>|
|[BIOMD0000000860](https://www.ebi.ac.uk/biomodels/BIOMD0000000860)<br/><sup>Proctor2017- Role of microRNAs in osteoarthritis (Positive Feedforward Incoherent By MicroRNA)_1</sup>|<details><summary>pass</summary>[proctor2017_model4.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000860#Files)</details>|FAIL|<details><summary>pass</summary>[proctor2017_model4.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000860#Files)</details>|pass|pass|
|[BIOMD0000000861](https://www.ebi.ac.uk/biomodels/BIOMD0000000861)<br/><sup>Bachmann2011 - Division of labor by dual feedback regulators controls JAK2/STAT5 signaling over broad ligand range</sup>|<details><summary>pass</summary>[Bachmann2011.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000861#Files)</details>|pass|<details><summary>pass</summary>[Bachmann2011.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000861#Files)</details>|pass|pass|
|[BIOMD0000000862](https://www.ebi.ac.uk/biomodels/BIOMD0000000862)<br/><sup>Proctor2017- Role of microRNAs in osteoarthritis (Positive Feedback By Micro RNA)</sup>|<details><summary>pass</summary>[Proctor2017_model0.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000862#Files)</details>|pass|<details><summary>pass</summary>[Proctor2017_model0.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000862#Files)</details>|pass|pass|
|[BIOMD0000000863](https://www.ebi.ac.uk/biomodels/BIOMD0000000863)<br/><sup>Kosinsky2018 - Radiation and PD-(L)1 treatment combinations</sup>|<details><summary>pass</summary>[Kosinsky2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000863#Files)</details>|FAIL|<details><summary>pass</summary>[Kosinsky2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000863#Files)</details>|pass|pass|
|[BIOMD0000000864](https://www.ebi.ac.uk/biomodels/BIOMD0000000864)<br/><sup>Proctor2017- Role of microRNAs in osteoarthritis (Negative Feedback By MicroRNA)</sup>|<details><summary>pass</summary>[Proctor2017_model1.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000864#Files)</details>|pass|<details><summary>pass</summary>[Proctor2017_model1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000864#Files)</details>|pass|pass|
|[BIOMD0000000865](https://www.ebi.ac.uk/biomodels/BIOMD0000000865)<br/><sup>Nikolaev2019 - Immunobiochemical reconstruction of influenza lung infection-melanoma skin cancer interactions</sup>|<details><summary>pass</summary>[Nikolaev2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000865#Files)</details>|pass|<details><summary>pass</summary>[Nikolaev2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000865#Files)</details>|pass|pass|
|[BIOMD0000000866](https://www.ebi.ac.uk/biomodels/BIOMD0000000866)<br/><sup>Simon2019 - NIK-dependent p100 processing into p52, Michaelis-Menten, SBML 2v4</sup>|<details><summary>pass</summary>[Simon2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000866#Files)</details>|pass|<details><summary>pass</summary>[Simon2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000866#Files)</details>|pass|pass|
|[BIOMD0000000867](https://www.ebi.ac.uk/biomodels/BIOMD0000000867)<br/><sup>Coulibaly2019 - Interleukin-15 Signaling in HIF-1a Regulation in Natural Killer Cells</sup>|<details><summary>pass</summary>[Coulibaly2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000867#Files)</details>|pass|<details><summary>pass</summary>[Coulibaly2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000867#Files)</details>|pass|pass|
|[BIOMD0000000868](https://www.ebi.ac.uk/biomodels/BIOMD0000000868)<br/><sup>Simon2019 - NIK-dependent p100 processing into p52, Mass Action, SBML 2v4</sup>|<details><summary>pass</summary>[simon2019_model2.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000868#Files)</details>|pass|<details><summary>pass</summary>[simon2019_model2.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000868#Files)</details>|pass|pass|
|[BIOMD0000000869](https://www.ebi.ac.uk/biomodels/BIOMD0000000869)<br/><sup>Simon2019 - NIK-dependent p100 processing into p52 and IkBd degradation, Michaelis-Menten, SBML 2v4</sup>|<details><summary>pass</summary>[Simon2019_model3.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000869#Files)</details>|pass|<details><summary>pass</summary>[Simon2019_model3.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000869#Files)</details>|pass|pass|
|[BIOMD0000000870](https://www.ebi.ac.uk/biomodels/BIOMD0000000870)<br/><sup>Simon2019 - NIK-dependent p100 processing into p52 and IkBd degradation, mass action, SBML 2v4</sup>|<details><summary>pass</summary>[Simon2019_model4.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000870#Files)</details>|pass|<details><summary>FAIL</summary>[Simon2019_model4.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000870#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Simon2019_model4.sedml```</details>|
|[BIOMD0000000871](https://www.ebi.ac.uk/biomodels/BIOMD0000000871)<br/><sup>NIK-dependent p100 processing into p52 with RelB binding and IkBd degradation, mass action, SBML 2v4</sup>|<details><summary>pass</summary>[Simon2019_Figure3b.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000871#Files)</details>|pass|<details><summary>pass</summary>[Simon2019_Figure3b.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000871#Files)</details>|pass|pass|
|[BIOMD0000000872](https://www.ebi.ac.uk/biomodels/BIOMD0000000872)<br/><sup>Verma2016 - HIV and HPV co-infection, T-cell response</sup>|<details><summary>FAIL</summary>[verma2017.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000872#Files)</details>|FAIL|<details><summary>pass</summary>[verma2017.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000872#Files)</details>|pass|pass|
|[BIOMD0000000873](https://www.ebi.ac.uk/biomodels/BIOMD0000000873)<br/><sup>Soni2018 - IL6 induced M2 Phenotype in Leishmania major infected macrophage</sup>|<details><summary>pass</summary>[Soni2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000873#Files)</details>|FAIL|<details><summary>pass</summary>[Soni2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000873#Files)</details>|pass|pass|
|[BIOMD0000000874](https://www.ebi.ac.uk/biomodels/BIOMD0000000874)<br/><sup>Perelson1993 - HIVinfection_CD4Tcells_ModelA</sup>|<details><summary>pass</summary>[Perelson1993.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000874#Files)</details>|pass|<details><summary>pass</summary>[Perelson1993.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000874#Files)</details>|pass|pass|
|[BIOMD0000000875](https://www.ebi.ac.uk/biomodels/BIOMD0000000875)<br/><sup>Nelson2000- HIV-1 general model 1</sup>|<details><summary>pass</summary>[Nelson2000.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000875#Files)</details>|FAIL|<details><summary>pass</summary>[Nelson2000.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000875#Files)</details>|pass|pass|
|[BIOMD0000000876](https://www.ebi.ac.uk/biomodels/BIOMD0000000876)<br/><sup>Aavani2019 - The role of CD4 T cells in immune system activation and viral reproduction in a simple model for HIV infection</sup>|<details><summary>pass</summary>[Aavani2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000876#Files)</details>|pass|<details><summary>pass</summary>[Aavani2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000876#Files)</details>|pass|pass|
|[BIOMD0000000877](https://www.ebi.ac.uk/biomodels/BIOMD0000000877)<br/><sup>Ontah2019 - Dynamic analysis of a tumor treatment model using oncolytic virus and chemotherapy with saturated infection rate</sup>|<details><summary>pass</summary>[Ontah2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000877#Files)</details>|pass|<details><summary>pass</summary>[Ontah2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000877#Files)</details>|pass|pass|
|[BIOMD0000000878](https://www.ebi.ac.uk/biomodels/BIOMD0000000878)<br/><sup>Lenbury2001_InsulinKineticsModel_A</sup>|<details><summary>pass</summary>[Lenbury2001.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000878#Files)</details>|pass|<details><summary>pass</summary>[Lenbury2001.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000878#Files)</details>|pass|<details><summary>FAIL (CV_TOO_MUCH_WORK)</summary>```CVODE Error: CV_TOO_MUCH_WORK: The solver took mxstep (20000) internal steps but could not reach tout.; In virtual double rr::CVODEIntegrator::integrate(double, double)```</details>|
|[BIOMD0000000879](https://www.ebi.ac.uk/biomodels/BIOMD0000000879)<br/><sup>Rodrigues2019 - A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia</sup>|<details><summary>pass</summary>[Rodrigues2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000879#Files)</details>|pass|<details><summary>pass</summary>[Rodrigues2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000879#Files)</details>|pass|pass|
|[BIOMD0000000880](https://www.ebi.ac.uk/biomodels/BIOMD0000000880)<br/><sup>Trisilowati2018 - Optimal control of tumor-immune system interaction with treatment</sup>|<details><summary>pass</summary>[Trisilowati2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000880#Files)</details>|pass|<details><summary>pass</summary>[Trisilowati2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000880#Files)</details>|pass|pass|
|[BIOMD0000000881](https://www.ebi.ac.uk/biomodels/BIOMD0000000881)<br/><sup>Kogan2013 - A mathematical model for the immunotherapeutic control of the TH1 TH2 imbalance in melanoma</sup>|<details><summary>pass</summary>[Kogan2013.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000881#Files)</details>|pass|<details><summary>pass</summary>[Kogan2013.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000881#Files)</details>|pass|pass|
|[BIOMD0000000882](https://www.ebi.ac.uk/biomodels/BIOMD0000000882)<br/><sup>Munz2009 - Zombie SIZRC</sup>|<details><summary>pass</summary>[munz2000.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000882#Files)</details>|pass|<details><summary>pass</summary>[munz2000.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000882#Files)</details>|pass|pass|
|[BIOMD0000000883](https://www.ebi.ac.uk/biomodels/BIOMD0000000883)<br/><sup>Giani2019 - Computational modeling to predict MAP3K8 effects as mediator of resistance to vemurafenib in thyroid cancer stem cells</sup>|<details><summary>pass</summary>[Giani2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000883#Files)</details>|pass|<details><summary>pass</summary>[Giani2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000883#Files)</details>|pass|pass|
|[BIOMD0000000884](https://www.ebi.ac.uk/biomodels/BIOMD0000000884)<br/><sup>Cortes2019 - Optimality of the spontaneous prophage induction rate.</sup>|<details><summary>pass</summary>[Cortes2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000884#Files)</details>|pass|<details><summary>FAIL</summary>[Cortes2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000884#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Cortes2019.sedml```</details>|
|[BIOMD0000000885](https://www.ebi.ac.uk/biomodels/BIOMD0000000885)<br/><sup>Sumana2018 - Mathematical modeling of cancer-immune system, considering the role of antibodies.</sup>|<details><summary>pass</summary>[Sumana2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000885#Files)</details>|pass|<details><summary>pass</summary>[Sumana2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000885#Files)</details>|pass|pass|
|[BIOMD0000000886](https://www.ebi.ac.uk/biomodels/BIOMD0000000886)<br/><sup>Dubey2008 - Modeling the interaction between avascular cancerous cells and acquired immune response</sup>|<details><summary>pass</summary>[Dubey2008.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000886#Files)</details>|pass|<details><summary>pass</summary>[Dubey2008.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000886#Files)</details>|pass|pass|
|[BIOMD0000000887](https://www.ebi.ac.uk/biomodels/BIOMD0000000887)<br/><sup>Lim2014 - HTLV-I infection A dynamic struggle between viral persistence and host immunity</sup>|<details><summary>pass</summary>[Lim2014.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000887#Files)</details>|pass|<details><summary>pass</summary>[Lim2014.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000887#Files)</details>|pass|pass|
|[BIOMD0000000888](https://www.ebi.ac.uk/biomodels/BIOMD0000000888)<br/><sup>Unni2019 - Mathematical Modeling, Analysis, and Simulation of Tumor Dynamics with Drug Interventions</sup>|<details><summary>pass</summary>[unni2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000888#Files)</details>|pass|<details><summary>pass</summary>[unni2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000888#Files)</details>|pass|pass|
|[BIOMD0000000889](https://www.ebi.ac.uk/biomodels/BIOMD0000000889)<br/><sup>Fribourg2014 - Model of influenza A virus infection dynamics of viral antagonism and innate immune response.</sup>|<details><summary>pass</summary>[Fribourg2014.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000889#Files)</details>|pass|<details><summary>pass</summary>[Fribourg2014.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000889#Files)</details>|pass|pass|
|[BIOMD0000000890](https://www.ebi.ac.uk/biomodels/BIOMD0000000890)<br/><sup>Bhattacharya2014 - A mathematical model of the sterol regulatory element binding protein 2 cholesterol biosynthesis pathway</sup>|<details><summary>pass</summary>[Bhattacharya2014.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000890#Files)</details>|FAIL|<details><summary>pass</summary>[Bhattacharya2014.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000890#Files)</details>|pass|pass|
|[BIOMD0000000891](https://www.ebi.ac.uk/biomodels/BIOMD0000000891)<br/><sup>Khajanchi2019 - Stability Analysis of a Mathematical Model forGlioma-Immune Interaction under OptimalTherapy</sup>|<details><summary>pass</summary>[Khajanchi2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000891#Files)</details>|pass|<details><summary>pass</summary>[Khajanchi2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000891#Files)</details>|pass|pass|
|[BIOMD0000000892](https://www.ebi.ac.uk/biomodels/BIOMD0000000892)<br/><sup>Sandip2013 - Modeling the dynamics of hepatitis C virus with combined antiviral drug therapy: interferon and ribavirin.</sup>|<details><summary>pass</summary>[Sandip2013.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000892#Files)</details>|pass|<details><summary>pass</summary>[Sandip2013.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000892#Files)</details>|pass|pass|
|[BIOMD0000000893](https://www.ebi.ac.uk/biomodels/BIOMD0000000893)<br/><sup>GonzalezMiranda2013 - The effect of circadian oscillations on biochemical cell signaling by NF-κB</sup>|<details><summary>pass</summary>[GonzalezMiranda2013.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000893#Files)</details>|FAIL|<details><summary>pass</summary>[GonzalezMiranda2013.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000893#Files)</details>|pass|pass|
|[BIOMD0000000894](https://www.ebi.ac.uk/biomodels/BIOMD0000000894)<br/><sup>Bose2011 - Noise-assisted interactions of tumor and immune cells</sup>|<details><summary>pass</summary>[Bose2011.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000894#Files)</details>|FAIL|<details><summary>pass</summary>[Bose2011.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000894#Files)</details>|pass|pass|
|[BIOMD0000000895](https://www.ebi.ac.uk/biomodels/BIOMD0000000895)<br/><sup>Schokker2013 - A mathematical model representing cellular immune development and response to Salmonella of chicken intestinal tissue</sup>|<details><summary>pass</summary>[Schokker2013.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000895#Files)</details>|FAIL|<details><summary>pass</summary>[Schokker2013.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000895#Files)</details>|pass|pass|
|[BIOMD0000000896](https://www.ebi.ac.uk/biomodels/BIOMD0000000896)<br/><sup>Szymanska2009 - Mathematical modeling of heat shock protein synthesis in response to temperature change</sup>|<details><summary>pass</summary>[Szymanska2009.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000896#Files)</details>|pass|<details><summary>pass</summary>[Szymanska2009.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000896#Files)</details>|pass|pass|
|[BIOMD0000000897](https://www.ebi.ac.uk/biomodels/BIOMD0000000897)<br/><sup>Khajanchi2015 - The combined effects of optimal control in cancer remission</sup>|<details><summary>pass</summary>[Khajanchi2015.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000897#Files)</details>|pass|<details><summary>FAIL</summary>[Khajanchi2015.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000897#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Khajanchi2015.sedml```</details>|
|[BIOMD0000000898](https://www.ebi.ac.uk/biomodels/BIOMD0000000898)<br/><sup>Jiao2018 - Feedback regulation in a stem cell model with acute myeloid leukaemia</sup>|<details><summary>pass</summary>[Jiao2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000898#Files)</details>|pass|<details><summary>pass</summary>[Jiao2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000898#Files)</details>|pass|pass|
|[BIOMD0000000899](https://www.ebi.ac.uk/biomodels/BIOMD0000000899)<br/><sup>Ota2015 - Positive regulation of Rho GTPase activity by RhoGDIs as a result of their direct interaction with GAPs (GDI integrated)</sup>|<details><summary>FAIL</summary>[Ota2015_GDI-integrated.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000899#Files)</details>|FAIL|<details><summary>pass</summary>[Ota2015_GDI-integrated.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000899#Files)</details>|pass|pass|
|[BIOMD0000000900](https://www.ebi.ac.uk/biomodels/BIOMD0000000900)<br/><sup>Bianca2013 - Persistence analysis in a Kolmogorov-type model for cancer-immune system competition</sup>|<details><summary>pass</summary>[Bianca2013.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000900#Files)</details>|pass|<details><summary>pass</summary>[Bianca2013.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000900#Files)</details>|pass|pass|
|[BIOMD0000000902](https://www.ebi.ac.uk/biomodels/BIOMD0000000902)<br/><sup>Wang2019 - A mathematical model of oncolytic virotherapy with time delay</sup>|<details><summary>pass</summary>[Wang2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000902#Files)</details>|pass|<details><summary>pass</summary>[Wang2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000902#Files)</details>|pass|pass|
|[BIOMD0000000903](https://www.ebi.ac.uk/biomodels/BIOMD0000000903)<br/><sup>Solis-perez2019 - A fractional mathematical model of breast cancer competition model</sup>|<details><summary>pass</summary>[Solis-perez2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000903#Files)</details>|pass|<details><summary>pass</summary>[Solis-perez2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000903#Files)</details>|pass|pass|
|[BIOMD0000000904](https://www.ebi.ac.uk/biomodels/BIOMD0000000904)<br/><sup>Admon2017 - Modelling tumor growth with immune response and drug using ordinary differential equations</sup>|<details><summary>pass</summary>[Admon2017.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000904#Files)</details>|pass|<details><summary>pass</summary>[Admon2017.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000904#Files)</details>|pass|pass|
|[BIOMD0000000905](https://www.ebi.ac.uk/biomodels/BIOMD0000000905)<br/><sup>Dubey2007 - A mathematical model for the effect of toxicant on the immune system (with toxicant effect) Model2</sup>|<details><summary>pass</summary>[Dubey2007_model2.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000905#Files)</details>|pass|<details><summary>pass</summary>[Dubey2007_model2.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000905#Files)</details>|pass|pass|
|[BIOMD0000000906](https://www.ebi.ac.uk/biomodels/BIOMD0000000906)<br/><sup>Dubey2007 - A mathematical model for the effect of toxicant on the immune system (without toxicant effect) Model1</sup>|<details><summary>pass</summary>[Dubey2007_model1.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000906#Files)</details>|pass|<details><summary>pass</summary>[Dubey2007_model1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000906#Files)</details>|pass|pass|
|[BIOMD0000000907](https://www.ebi.ac.uk/biomodels/BIOMD0000000907)<br/><sup>HeberleRazquinNavas2019 - The PI3K and MAPK/p38 pathways control stress granuleassembly in a hierarchical manner model 3</sup>|<details><summary>pass</summary>[Navas2019_model3.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000907#Files)</details>|FAIL|<details><summary>pass</summary>[Navas2019_model3.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000907#Files)</details>|pass|pass|
|[BIOMD0000000908](https://www.ebi.ac.uk/biomodels/BIOMD0000000908)<br/><sup>dePillis2013 - Mathematical modeling of regulatory T cell effects on renal cell carcinoma treatment</sup>|<details><summary>pass</summary>[dePillis2013.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000908#Files)</details>|pass|<details><summary>pass</summary>[dePillis2013.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000908#Files)</details>|pass|pass|
|[BIOMD0000000909](https://www.ebi.ac.uk/biomodels/BIOMD0000000909)<br/><sup>dePillis2003 - The dynamics of an optimally controlled tumor model: A case study</sup>|<details><summary>pass</summary>[dePillis2003.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000909#Files)</details>|FAIL|<details><summary>pass</summary>[dePillis2003.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000909#Files)</details>|pass|pass|
|[BIOMD0000000910](https://www.ebi.ac.uk/biomodels/BIOMD0000000910)<br/><sup>Isaeva2008 - Modelling of Anti-Tumour Immune Response Immunocorrective Effect of Weak Centimetre Electromagnetic Waves</sup>|<details><summary>pass</summary>[Isaeva2008.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000910#Files)</details>|pass|<details><summary>pass</summary>[Isaeva2008.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000910#Files)</details>|pass|pass|
|[BIOMD0000000911](https://www.ebi.ac.uk/biomodels/BIOMD0000000911)<br/><sup>Merola2008 - An insight into tumor dormancy equilibrium via the analysis of its domain of attraction</sup>|<details><summary>pass</summary>[Merola2008.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000911#Files)</details>|pass|<details><summary>pass</summary>[Merola2008.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000911#Files)</details>|pass|pass|
|[BIOMD0000000912](https://www.ebi.ac.uk/biomodels/BIOMD0000000912)<br/><sup>Caravagna2010 - Tumour suppression by immune system</sup>|<details><summary>pass</summary>[Caravagna2010.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000912#Files)</details>|pass|<details><summary>FAIL</summary>[Caravagna2010.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000912#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Caravagna2010.sedml```</details>|
|[BIOMD0000000913](https://www.ebi.ac.uk/biomodels/BIOMD0000000913)<br/><sup>dePillis2008 - Optimal control of mixed immunotherapy and chemotherapy of tumors</sup>|<details><summary>pass</summary>[dePillis2008.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000913#Files)</details>|pass|<details><summary>pass</summary>[dePillis2008.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000913#Files)</details>|pass|pass|
|[BIOMD0000000914](https://www.ebi.ac.uk/biomodels/BIOMD0000000914)<br/><sup>Parra_Guillen2013 -  Mathematical model approach to describe tumour response in mice after vaccine administration_model1</sup>|<details><summary>pass</summary>[Parra_Guillen2013.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000914#Files)</details>|FAIL|<details><summary>pass</summary>[Parra_Guillen2013.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000914#Files)</details>|pass|pass|
|[BIOMD0000000915](https://www.ebi.ac.uk/biomodels/BIOMD0000000915)<br/><sup>Sun2018 - Instantaneous mutation rate in cancer initiation and progression</sup>|<details><summary>pass</summary>[Sun2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000915#Files)</details>|pass|<details><summary>pass</summary>[Sun2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000915#Files)</details>|pass|pass|
|[BIOMD0000000916](https://www.ebi.ac.uk/biomodels/BIOMD0000000916)<br/><sup>Kraan199_Kinetics of Cortisol Metabolism and Excretion.</sup>|<details><summary>pass</summary>[Kraan1992.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000916#Files)</details>|pass|<details><summary>pass</summary>[Kraan1992.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000916#Files)</details>|pass|pass|
|[BIOMD0000000917](https://www.ebi.ac.uk/biomodels/BIOMD0000000917)<br/><sup>Phillips2007_AscendingArousalSystem_SleepWakeDynamics</sup>|<details><summary>pass</summary>[Phillips2007_Curated.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000917#Files)</details>|pass|<details><summary>FAIL</summary>[Phillips2007.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000917#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Phillips2007.sedml```</details>|
|[BIOMD0000000918](https://www.ebi.ac.uk/biomodels/BIOMD0000000918)<br/><sup>Schwarz2018-Cdk Activity Threshold Determines Passage through the Restriction Point</sup>|<details><summary>pass</summary>[Schwarz2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000918#Files)</details>|pass|<details><summary>FAIL</summary>[Schwarz2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000918#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Schwarz2018.sedml```</details>|
|[BIOMD0000000919](https://www.ebi.ac.uk/biomodels/BIOMD0000000919)<br/><sup>Ledzewicz2013 - On optimal chemotherapy with a strongly targeted agent for a model of tumor immune system interactions with generalized logistic growth</sup>|<details><summary>pass</summary>[Ledzewicz2013.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000919#Files)</details>|pass|<details><summary>FAIL</summary>[Ledzewicz2013.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000919#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Ledzewicz2013.sedml```</details>|
|[BIOMD0000000920](https://www.ebi.ac.uk/biomodels/BIOMD0000000920)<br/><sup>Jarrett2015 - Modelling the interaction between immune response, bacterial dynamics and inflammatory damage</sup>|<details><summary>pass</summary>[Jarrett2015.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000920#Files)</details>|pass|<details><summary>pass</summary>[Jarrett2015.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000920#Files)</details>|pass|pass|
|[BIOMD0000000921](https://www.ebi.ac.uk/biomodels/BIOMD0000000921)<br/><sup>Khajanchi2017 - Uniform Persistence and Global Stability for a Brain Tumor and Immune System Interaction</sup>|<details><summary>pass</summary>[khajanchi2017.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000921#Files)</details>|pass|<details><summary>pass</summary>[khajanchi2017.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000921#Files)</details>|pass|pass|
|[BIOMD0000000922](https://www.ebi.ac.uk/biomodels/BIOMD0000000922)<br/><sup>Turner2015-Human/Mosquito ELP Model</sup>|<details><summary>pass</summary>[Turner2015_ELP.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000922#Files)</details>|pass|<details><summary>FAIL</summary>[Turner2015_ELP.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000922#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Turner2015_ELP.sedml```</details>|
|[BIOMD0000000923](https://www.ebi.ac.uk/biomodels/BIOMD0000000923)<br/><sup>Liò2012_Modelling osteomyelitis_Control Model</sup>|<details><summary>pass</summary>[Liò2012_Modelling osteomyelitis_Control Model.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000923#Files)</details>|FAIL|<details><summary>pass</summary>[Liò2012_Modelling osteomyelitis_Control Model.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000923#Files)</details>|pass|pass|
|[BIOMD0000000925](https://www.ebi.ac.uk/biomodels/BIOMD0000000925)<br/><sup>Dunster2016 - Nondimensional Coagulation Model</sup>|<details><summary>FAIL</summary>[Dunster2016_Nondimensional_Model_Curated.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000925#Files)</details>|FAIL|<details><summary>pass</summary>[Dunster2016_Nondimensional_Model1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000925#Files)</details>|pass|<details><summary>FAIL (noSBMLelement)</summary>```No sbml element exists for concentration selection '[Inactive_Factor_V]'```</details>|
|[BIOMD0000000926](https://www.ebi.ac.uk/biomodels/BIOMD0000000926)<br/><sup>Rhodes2019 - Immune-Mediated theory of Metastasis</sup>|<details><summary>pass</summary>[Rhodes2019-Immune-Mediated theory of Metastasis_V1.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000926#Files)</details>|FAIL|<details><summary>pass</summary>[Rhodes2019-Immune-Mediated theory of Metastasis_V1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000926#Files)</details>|pass|pass|
|[BIOMD0000000927](https://www.ebi.ac.uk/biomodels/BIOMD0000000927)<br/><sup>Grigolon2018-Responses to auxin signals</sup>|<details><summary>pass</summary>[Grigolon2018_fig1b.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000927#Files)</details>|pass|<details><summary>pass</summary>[Grigolon2018_fig1b.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000927#Files)</details>|pass|pass|
|[BIOMD0000000929](https://www.ebi.ac.uk/biomodels/BIOMD0000000929)<br/><sup>Li2016 - Model for pancreatic cancer patients receiving immunotherapy</sup>|<details><summary>pass</summary>[Li2016.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000929#Files)</details>|pass|<details><summary>FAIL</summary>[Li2016.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000929#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Li2016.sedml```</details>|
|[BIOMD0000000930](https://www.ebi.ac.uk/biomodels/BIOMD0000000930)<br/><sup>Liu2017 - chemotherapy targeted model of tumor immune system</sup>|<details><summary>pass</summary>[Liu2017.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000930#Files)</details>|pass|<details><summary>pass</summary>[Liu2017.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000930#Files)</details>|pass|pass|
|[BIOMD0000000931](https://www.ebi.ac.uk/biomodels/BIOMD0000000931)<br/><sup>Voliotis2019-GnRH Pulse Generation</sup>|<details><summary>pass</summary>[Voliotis2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000931#Files)</details>|pass|<details><summary>pass</summary>[Voliotis2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000931#Files)</details>|pass|<details><summary>FAIL (noSBMLelement)</summary>```No sbml element exists for symbol 'Firing_Rate__HZ'```</details>|
|[BIOMD0000000933](https://www.ebi.ac.uk/biomodels/BIOMD0000000933)<br/><sup>Kosiuk2015-Geometric analysis of the Goldbeter minimal model for the embryonic cell cycle</sup>|<details><summary>pass</summary>[Kosiuk2015.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000933#Files)</details>|pass|<details><summary>pass</summary>[Kosiuk2015.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000933#Files)</details>|pass|pass|
|[BIOMD0000000935](https://www.ebi.ac.uk/biomodels/BIOMD0000000935)<br/><sup>Ferrel2011 - Cdk1 and APC regulation in cell cycle in Xenopus laevis</sup>|<details><summary>pass</summary>[Ferrel2011.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000935#Files)</details>|pass|<details><summary>pass</summary>[Ferrel2011.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000935#Files)</details>|pass|pass|
|[BIOMD0000000936](https://www.ebi.ac.uk/biomodels/BIOMD0000000936)<br/><sup>ferrel2011 - autonomous biochemical oscillator in cell cycle in Xenopus laevis v2</sup>|<details><summary>pass</summary>[Ferrel2011_V2.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000936#Files)</details>|FAIL|<details><summary>pass</summary>[Ferrel2011_V2.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000936#Files)</details>|pass|pass|
|[BIOMD0000000937](https://www.ebi.ac.uk/biomodels/BIOMD0000000937)<br/><sup>Ferrel2011 - Autonomous biochemical oscillator in regulation of CDK1, Plk1, and APC in Xenopus Laevis cell cycle</sup>|<details><summary>pass</summary>[Ferrel2011_V3.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000937#Files)</details>|pass|<details><summary>pass</summary>[Ferrel2011_V3.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000937#Files)</details>|pass|pass|
|[BIOMD0000000938](https://www.ebi.ac.uk/biomodels/BIOMD0000000938)<br/><sup>Gerard2013 - Model 3 - Embryonic-type eukaryotic Cell Cycle regulation based on negative feedback between Cdk/cyclin and APC and competitive inhibition between Cdk/cyclin and securin for polyubiquitylation_1</sup>|<details><summary>pass</summary>[Gerard2013.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000938#Files)</details>|pass|<details><summary>pass</summary>[Gerard2013.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000938#Files)</details>|pass|pass|
|[BIOMD0000000940](https://www.ebi.ac.uk/biomodels/BIOMD0000000940)<br/><sup>Tang2019 - Pharmacology modelling of AURKB and ZAK interaction in TNBC</sup>|<details><summary>pass</summary>[Tang2019.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000940#Files)</details>|pass|<details><summary>FAIL</summary>[Tang2019.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000940#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Tang2019.sedml```</details>|
|[BIOMD0000000941](https://www.ebi.ac.uk/biomodels/BIOMD0000000941)<br/><sup>Gerard2010 - Progression of mammalian cell cycle by successive activation of various cyclin cdk complexes</sup>|<details><summary>pass</summary>[gerard2010.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000941#Files)</details>|pass|<details><summary>pass</summary>[gerard2010.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000941#Files)</details>|pass|pass|
|[BIOMD0000000942](https://www.ebi.ac.uk/biomodels/BIOMD0000000942)<br/><sup>Sible2007 - Mitotic cell cycle mecanism in Xenopus Laevis</sup>|<details><summary>pass</summary>[Sible2007.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000942#Files)</details>|pass|<details><summary>pass</summary>[Sible2007.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000942#Files)</details>|pass|pass|
|[BIOMD0000000943](https://www.ebi.ac.uk/biomodels/BIOMD0000000943)<br/><sup>Hat2016 - Reponse of p53 System to irradiation in cell fate decision making</sup>|<details><summary>pass</summary>[Hat2016.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000943#Files)</details>|pass|<details><summary>pass</summary>[Hat2016.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000943#Files)</details>|pass|pass|
|[BIOMD0000000944](https://www.ebi.ac.uk/biomodels/BIOMD0000000944)<br/><sup>Goldbeter2013-Oscillatory activity of cyclin-dependent kinases in the cell cycle</sup>|<details><summary>pass</summary>[Goldbeter2013.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000944#Files)</details>|pass|<details><summary>pass</summary>[Goldbeter2013.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000944#Files)</details>|pass|pass|
|[BIOMD0000000945](https://www.ebi.ac.uk/biomodels/BIOMD0000000945)<br/><sup>Evans2004 - Cell based mathematical model of topotecan</sup>|<details><summary>pass</summary>[Evans2004.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000945#Files)</details>|pass|<details><summary>pass</summary>[Evans2004.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000945#Files)</details>|pass|pass|
|[BIOMD0000000946](https://www.ebi.ac.uk/biomodels/BIOMD0000000946)<br/><sup>Evans2005 - Compartmental model for antineoplastic drug topotecan in breast cancer cells</sup>|<details><summary>pass</summary>[Evans2005.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000946#Files)</details>|pass|<details><summary>pass</summary>[Evans2005.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000946#Files)</details>|pass|pass|
|[BIOMD0000000947](https://www.ebi.ac.uk/biomodels/BIOMD0000000947)<br/><sup>Lee2017 - Paracetamol first-pass metabolism PK model</sup>|<details><summary>pass</summary>[Lee2017_Paracetamol_Metabolism.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000947#Files)</details>|pass|<details><summary>pass</summary>[Evans2005.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000947#Files)</details>|pass|<details><summary>FAIL (noSBMLelement)</summary>```No sbml element exists for concentration selection '[L_c]'```</details>|
|[BIOMD0000000948](https://www.ebi.ac.uk/biomodels/BIOMD0000000948)<br/><sup>Landberg2009 - Alkylresorcinol Dose Response</sup>|<details><summary>pass</summary>[Landberg2009.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000948#Files)</details>|FAIL|<details><summary>pass</summary>[Landberg2009.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000948#Files)</details>|pass|pass|
|[BIOMD0000000949](https://www.ebi.ac.uk/biomodels/BIOMD0000000949)<br/><sup>Chitnis2008 - Mathematical model of malaria transmission</sup>|<details><summary>pass</summary>[Chitnis2008.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000949#Files)</details>|pass|<details><summary>pass</summary>[Chitnis2008.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000949#Files)</details>|pass|pass|
|[BIOMD0000000950](https://www.ebi.ac.uk/biomodels/BIOMD0000000950)<br/><sup>Chitnis2012 - Model Rift Valley Fever transmission between cattle and mosquitoes (Model 1)</sup>|<details><summary>pass</summary>[Chitnis2012_model_1.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000950#Files)</details>|pass|<details><summary>pass</summary>[Chitnis2012_model_1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000950#Files)</details>|pass|pass|
|[BIOMD0000000952](https://www.ebi.ac.uk/biomodels/BIOMD0000000952)<br/><sup>Rodenfels2019 - Heat Oscillations Driven by the Embryonic Cell Cycle Reveal the Energetic Costs of Signaling</sup>|<details><summary>pass</summary>[Rodenfels2019_V1.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000952#Files)</details>|pass|<details><summary>FAIL</summary>[Rodenfels2019_V1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000952#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Rodenfels2019_V1.sedml```</details>|
|[BIOMD0000000953](https://www.ebi.ac.uk/biomodels/BIOMD0000000953)<br/><sup>Queralt2006 - Initiation of mitotic exit by downregulation of PP2A in budding yeast</sup>|<details><summary>pass</summary>[queralt2006_final.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000953#Files)</details>|FAIL|<details><summary>pass</summary>[queralt2006_final.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000953#Files)</details>|pass|pass|
|[BIOMD0000000955](https://www.ebi.ac.uk/biomodels/BIOMD0000000955)<br/><sup>Giordano2020 - SIDARTHE model of COVID-19 spread in Italy</sup>|<details><summary>pass</summary>[Giordano2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000955#Files)</details>|FAIL|<details><summary>pass</summary>[Giordano2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000955#Files)</details>|pass|pass|
|[BIOMD0000000956](https://www.ebi.ac.uk/biomodels/BIOMD0000000956)<br/><sup>Bertozzi2020 - SIR model of scenarios of COVID-19 spread in CA and NY</sup>|<details><summary>pass</summary>[Bertozzi2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000956#Files)</details>|pass|<details><summary>pass</summary>[Bertozzi2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000956#Files)</details>|pass|pass|
|[BIOMD0000000957](https://www.ebi.ac.uk/biomodels/BIOMD0000000957)<br/><sup>Roda2020 - SIR model of COVID-19 spread in Wuhan</sup>|<details><summary>pass</summary>[Roda2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000957#Files)</details>|pass|<details><summary>pass</summary>[Roda2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000957#Files)</details>|pass|pass|
|[BIOMD0000000958](https://www.ebi.ac.uk/biomodels/BIOMD0000000958)<br/><sup>Ndairou2020 - early-stage transmission dynamics of COVID-19 in Wuhan</sup>|<details><summary>pass</summary>[Ndairou2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000958#Files)</details>|FAIL|<details><summary>FAIL</summary>[Ndairou2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000958#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Ndairou2020.sedml```</details>|
|[BIOMD0000000959](https://www.ebi.ac.uk/biomodels/BIOMD0000000959)<br/><sup>Kok2020 - IFNalpha-induced signaling in Huh7.5 cells</sup>|<details><summary>pass</summary>[Kok2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000959#Files)</details>|pass|<details><summary>pass</summary>[Kok2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000959#Files)</details>|pass|pass|
|[BIOMD0000000960](https://www.ebi.ac.uk/biomodels/BIOMD0000000960)<br/><sup>Paiva2020 - SEIAHRD model of transmission dynamics of COVID-19</sup>|<details><summary>pass</summary>[Paiva2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000960#Files)</details>|pass|<details><summary>pass</summary>[Paiva2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000960#Files)</details>|pass|pass|
|[BIOMD0000000961](https://www.ebi.ac.uk/biomodels/BIOMD0000000961)<br/><sup>McDougal2017 - Metabolism in ischemic cardiomyocytes</sup>|<details><summary>FAIL</summary>[McDougal2017.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000961#Files)</details>|FAIL|<details><summary>pass</summary>[McDougal2017.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000961#Files)</details>|pass|pass|
|[BIOMD0000000962](https://www.ebi.ac.uk/biomodels/BIOMD0000000962)<br/><sup>Zhao2020 - SUQC model of COVID-19 transmission dynamics in Wuhan, Hubei, and China</sup>|<details><summary>pass</summary>[Zhao2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000962#Files)</details>|pass|<details><summary>FAIL</summary>[Zhao2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000962#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Zhao2020.sedml```</details>|
|[BIOMD0000000963](https://www.ebi.ac.uk/biomodels/BIOMD0000000963)<br/><sup>Weitz2020 - SIR model of COVID-19 transmission with shielding</sup>|<details><summary>pass</summary>[Weitz2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000963#Files)</details>|pass|<details><summary>pass</summary>[Weitz2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000963#Files)</details>|pass|pass|
|[BIOMD0000000964](https://www.ebi.ac.uk/biomodels/BIOMD0000000964)<br/><sup>Mwalili2020 - SEIR model of COVID-19 transmission and environmental pathogen prevalence</sup>|<details><summary>pass</summary>[Mwalili2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000964#Files)</details>|FAIL|<details><summary>pass</summary>[Mwalili2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000964#Files)</details>|pass|pass|
|[BIOMD0000000965](https://www.ebi.ac.uk/biomodels/BIOMD0000000965)<br/><sup>LeBeau1999 - IP3-dependent intracellular calcium oscillations due to agonist stimulation from Cholecytokinin</sup>|<details><summary>FAIL</summary>[LeBeau1999_Phosphorylation_CCK.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000965#Files)</details>|FAIL|<details><summary>pass</summary>[LeBeau1999_Phosphorylation_CCK.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000965#Files)</details>|pass|pass|
|[BIOMD0000000966](https://www.ebi.ac.uk/biomodels/BIOMD0000000966)<br/><sup>Cui2008 - in vitro transcriptional response of zinc homeostasis system in Escherichia coli</sup>|<details><summary>FAIL</summary>[Cui2008.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000966#Files)</details>|FAIL|<details><summary>pass</summary>[Cui2008.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000966#Files)</details>|pass|pass|
|[BIOMD0000000967](https://www.ebi.ac.uk/biomodels/BIOMD0000000967)<br/><sup>McLean1991 - Behaviour of HIV in the presence of zidovudine</sup>|<details><summary>FAIL</summary>[McLean1991.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000967#Files)</details>|FAIL|<details><summary>pass</summary>[McLean1991.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000967#Files)</details>|pass|pass|
|[BIOMD0000000968](https://www.ebi.ac.uk/biomodels/BIOMD0000000968)<br/><sup>Palmer2008 - Negative Feedback in IL-7 mediated Jak-Stat signaling</sup>|<details><summary>pass</summary>[Palmer2008.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000968#Files)</details>|pass|<details><summary>pass</summary>[Palmer2008.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000968#Files)</details>|pass|pass|
|[BIOMD0000000969](https://www.ebi.ac.uk/biomodels/BIOMD0000000969)<br/><sup>Cuadros2020 - SIHRD spatiotemporal model of COVID-19 transmission in Ohio</sup>|<details><summary>pass</summary>[Cuadros2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000969#Files)</details>|pass|<details><summary>pass</summary>[Cuadros2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000969#Files)</details>|pass|pass|
|[BIOMD0000000970](https://www.ebi.ac.uk/biomodels/BIOMD0000000970)<br/><sup>Hou2020 - SEIR model of COVID-19 transmission in Wuhan</sup>|<details><summary>pass</summary>[Hou2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000970#Files)</details>|pass|<details><summary>pass</summary>[Hou2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000970#Files)</details>|pass|pass|
|[BIOMD0000000971](https://www.ebi.ac.uk/biomodels/BIOMD0000000971)<br/><sup>Tang2020 - Estimation of transmission risk of COVID-19 and impact of public health interventions</sup>|<details><summary>pass</summary>[Tang2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000971#Files)</details>|pass|<details><summary>pass</summary>[Tang2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000971#Files)</details>|pass|pass|
|[BIOMD0000000972](https://www.ebi.ac.uk/biomodels/BIOMD0000000972)<br/><sup>Tang2020 - Estimation of transmission risk of COVID-19 and impact of public health interventions - update</sup>|<details><summary>pass</summary>[Tang2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000972#Files)</details>|pass|<details><summary>pass</summary>[Tang2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000972#Files)</details>|pass|pass|
|[BIOMD0000000973](https://www.ebi.ac.uk/biomodels/BIOMD0000000973)<br/><sup>Dasgupta2020 - Reduced model of receptor clusturing and aggregation</sup>|<details><summary>pass</summary>[Dasgupta2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000973#Files)</details>|pass|<details><summary>pass</summary>[Dasgupta2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000973#Files)</details>|pass|pass|
|[BIOMD0000000974](https://www.ebi.ac.uk/biomodels/BIOMD0000000974)<br/><sup>Carcione2020 - Deterministic SEIR simulation of a COVID-19 outbreak</sup>|<details><summary>pass</summary>[Carcione2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000974#Files)</details>|pass|<details><summary>pass</summary>[Carcione2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000974#Files)</details>|pass|pass|
|[BIOMD0000000975](https://www.ebi.ac.uk/biomodels/BIOMD0000000975)<br/><sup>Leloup2004 - Mammalian Circadian Rhythm models for 23.8 and 24.2 hours timeperiod</sup>|<details><summary>pass</summary>[Leloup2004_Set1.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000975#Files)</details>|FAIL|<details><summary>pass</summary>[Leloup2004_Set1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000975#Files)</details>|pass|pass|
|[BIOMD0000000976](https://www.ebi.ac.uk/biomodels/BIOMD0000000976)<br/><sup>Ghanbari2020 - forecasting the second wave of COVID-19 in Iran</sup>|<details><summary>pass</summary>[Ghanbari2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000976#Files)</details>|pass|<details><summary>pass</summary>[Ghanbari2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000976#Files)</details>|pass|pass|
|[BIOMD0000000977](https://www.ebi.ac.uk/biomodels/BIOMD0000000977)<br/><sup>Sarkar2020 - SAIR model of COVID-19 transmission with quarantine measures in India</sup>|<details><summary>pass</summary>[Sarkar2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000977#Files)</details>|pass|<details><summary>pass</summary>[Sarkar2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000977#Files)</details>|pass|pass|
|[BIOMD0000000978](https://www.ebi.ac.uk/biomodels/BIOMD0000000978)<br/><sup>Mukandavire2020 - SEIR model of early COVID-19 transmission in South Africa</sup>|<details><summary>pass</summary>[Mukandavire2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000978#Files)</details>|pass|<details><summary>pass</summary>[Mukandavire2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000978#Files)</details>|pass|pass|
|[BIOMD0000000979](https://www.ebi.ac.uk/biomodels/BIOMD0000000979)<br/><sup>Malkov2020 - SEIRS model of COVID-19 transmission with reinfection</sup>|<details><summary>pass</summary>[Malkov2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000979#Files)</details>|pass|<details><summary>pass</summary>[Malkov2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000979#Files)</details>|pass|<details><summary>FAIL (outOfRange)</summary>```list index out of range```</details>|
|[BIOMD0000000980](https://www.ebi.ac.uk/biomodels/BIOMD0000000980)<br/><sup>Malkov2020 - SEIRS model of COVID-19 transmission with time-varying R values and reinfection</sup>|<details><summary>pass</summary>[Malkov2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000980#Files)</details>|pass|<details><summary>pass</summary>[Malkov2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000980#Files)</details>|pass|<details><summary>FAIL (outOfRange)</summary>```list index out of range```</details>|
|[BIOMD0000000981](https://www.ebi.ac.uk/biomodels/BIOMD0000000981)<br/><sup>Wan2020 - risk estimation and prediction of the transmission of COVID-19 in maninland China excluding Hubei province</sup>|<details><summary>pass</summary>[Wan2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000981#Files)</details>|pass|<details><summary>pass</summary>[Wan2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000981#Files)</details>|pass|pass|
|[BIOMD0000000982](https://www.ebi.ac.uk/biomodels/BIOMD0000000982)<br/><sup>Law2020 - SIR model of COVID-19 transmission in Malyasia with time-varying parameters</sup>|<details><summary>pass</summary>[Law2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000982#Files)</details>|FAIL|<details><summary>pass</summary>[Law2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000982#Files)</details>|pass|pass|
|[BIOMD0000000983](https://www.ebi.ac.uk/biomodels/BIOMD0000000983)<br/><sup>Zongo2020 - model of COVID-19 transmission dynamics under containment measures in France</sup>|<details><summary>pass</summary>[Zongo2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000983#Files)</details>|pass|<details><summary>pass</summary>[Zongo2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000983#Files)</details>|pass|pass|
|[BIOMD0000000984](https://www.ebi.ac.uk/biomodels/BIOMD0000000984)<br/><sup>Fang2020 - SEIR model of COVID-19 transmission considering government interventions in Wuhan</sup>|<details><summary>pass</summary>[Fang2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000984#Files)</details>|pass|<details><summary>pass</summary>[Fang2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000984#Files)</details>|pass|pass|
|[BIOMD0000000985](https://www.ebi.ac.uk/biomodels/BIOMD0000000985)<br/><sup>Gex-Fabry1984 - model of receptor-mediated endocytosis of EGF in BALB/c 3T3 cells</sup>|<details><summary>pass</summary>[Gex-Fabry1984.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000985#Files)</details>|pass|<details><summary>pass</summary>[Gex-Fabry1984.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000985#Files)</details>|pass|pass|
|[BIOMD0000000986](https://www.ebi.ac.uk/biomodels/BIOMD0000000986)<br/><sup>Aubry1995 - Multi-compartment model of fluid-phase endocytosis kinetics in Dictyostelium discoideum</sup>|<details><summary>pass</summary>[Aubry1995.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000986#Files)</details>|pass|<details><summary>pass</summary>[Aubry1995.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000986#Files)</details>|pass|pass|
|[BIOMD0000000987](https://www.ebi.ac.uk/biomodels/BIOMD0000000987)<br/><sup>Aubry1995 - Nine-compartment model of fluid-phase endocytosis kinetics in Dictyostelium discoideum</sup>|<details><summary>pass</summary>[Aubry1995.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000987#Files)</details>|pass|<details><summary>pass</summary>[Aubry1995.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000987#Files)</details>|pass|pass|
|[BIOMD0000000988](https://www.ebi.ac.uk/biomodels/BIOMD0000000988)<br/><sup>Westerhoff2020 - systems biology model of the coronavirus pandemic 2020</sup>|<details><summary>FAIL</summary>[Westerhoff2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000988#Files)</details>|FAIL|<details><summary>pass</summary>[Westerhoff2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000988#Files)</details>|pass|pass|
|[BIOMD0000000989](https://www.ebi.ac.uk/biomodels/BIOMD0000000989)<br/><sup>Strasen2018 - TGFb SMAD Signalling - Dose dependent dynamics upon TGFb stimulation</sup>|<details><summary>pass</summary>[MODEL1712050001.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000989#Files)</details>|FAIL|<details><summary>FAIL</summary>[MODEL1712050001.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000989#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file MODEL1712050001.sedml```</details>|
|[BIOMD0000000990](https://www.ebi.ac.uk/biomodels/BIOMD0000000990)<br/><sup>Strasen2018 - TGFb SMAD Signalling - Degradation of 25pM ligand (TGFb)</sup>|<details><summary>pass</summary>[MODEL1712050002.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000990#Files)</details>|FAIL|<details><summary>FAIL</summary>[MODEL1712050002.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000990#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file MODEL1712050002.sedml```</details>|
|[BIOMD0000000991](https://www.ebi.ac.uk/biomodels/BIOMD0000000991)<br/><sup>Okuonghae2020 - SEAIR model of COVID-19 transmission in Lagos, Nigeria</sup>|<details><summary>pass</summary>[Okuonghae2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000991#Files)</details>|FAIL|<details><summary>pass</summary>[Okuonghae2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000991#Files)</details>|pass|pass|
|[BIOMD0000000994](https://www.ebi.ac.uk/biomodels/BIOMD0000000994)<br/><sup>Strasen2018 - TGFb SMAD Signalling - Restimulation with 5pM TGFb at 3hr</sup>|<details><summary>pass</summary>[MODEL1712050003.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000994#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1712050003.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000994#Files)</details>|pass|pass|
|[BIOMD0000000995](https://www.ebi.ac.uk/biomodels/BIOMD0000000995)<br/><sup>Strasen2018 - TGFb SMAD Signalling - Restimulation with 5pM TGFb at 8hr</sup>|<details><summary>pass</summary>[MODEL1712050004.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000995#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1712050004.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000995#Files)</details>|pass|pass|
|[BIOMD0000000996](https://www.ebi.ac.uk/biomodels/BIOMD0000000996)<br/><sup>Strasen2018 - TGFb SMAD Signalling - Restimulation with 100pM TGFb at 6hr</sup>|<details><summary>pass</summary>[MODEL1712050005.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000996#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1712050005.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000996#Files)</details>|pass|pass|
|[BIOMD0000000997](https://www.ebi.ac.uk/biomodels/BIOMD0000000997)<br/><sup>Strasen2018 - TGFb SMAD Signalling - DRB treatment</sup>|<details><summary>pass</summary>[MODEL1712050006.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000997#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1712050006.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000997#Files)</details>|pass|pass|
|[BIOMD0000000998](https://www.ebi.ac.uk/biomodels/BIOMD0000000998)<br/><sup>Strasen2018 - TGFb SMAD Signalling Class 1</sup>|<details><summary>pass</summary>[MODEL1712050007.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000998#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1712050007.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000998#Files)</details>|pass|pass|
|[BIOMD0000000999](https://www.ebi.ac.uk/biomodels/BIOMD0000000999)<br/><sup>Strasen2018 - TGFb SMAD Signalling Class 2</sup>|<details><summary>pass</summary>[MODEL1712050008.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000000999#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1712050008.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000000999#Files)</details>|pass|pass|
|[BIOMD0000001000](https://www.ebi.ac.uk/biomodels/BIOMD0000001000)<br/><sup>Strasen2018 - TGFb SMAD Signalling Class 3</sup>|<details><summary>pass</summary>[MODEL1712050009.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001000#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1712050009.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001000#Files)</details>|pass|pass|
|[BIOMD0000001001](https://www.ebi.ac.uk/biomodels/BIOMD0000001001)<br/><sup>Strasen2018 - TGFb SMAD Signalling Class 4</sup>|<details><summary>pass</summary>[MODEL1712050010.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001001#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1712050010.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001001#Files)</details>|pass|pass|
|[BIOMD0000001002](https://www.ebi.ac.uk/biomodels/BIOMD0000001002)<br/><sup>Strasen2018 - TGFb SMAD Signalling Class 5</sup>|<details><summary>pass</summary>[MODEL1712050011.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001002#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL1712050011.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001002#Files)</details>|pass|pass|
|[BIOMD0000001003](https://www.ebi.ac.uk/biomodels/BIOMD0000001003)<br/><sup>Strasen2018 - TGFb SMAD Signalling Class 6</sup>|<details><summary>pass</summary>[MODEL17120500012.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001003#Files)</details>|FAIL|<details><summary>pass</summary>[MODEL17120500012.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001003#Files)</details>|pass|pass|
|[BIOMD0000001004](https://www.ebi.ac.uk/biomodels/BIOMD0000001004)<br/><sup>Intosalmi2015 - Th17 core network model</sup>|<details><summary>pass</summary>[Intosalmi2015.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001004#Files)</details>|pass|<details><summary>FAIL</summary>[Intosalmi2015.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001004#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Intosalmi2015.sedml```</details>|
|[BIOMD0000001005](https://www.ebi.ac.uk/biomodels/BIOMD0000001005)<br/><sup>Bae2017 - Mathematical analysis of circadian disruption and metabolic re-entrainment of hepatic gluconeogenesis</sup>|<details><summary>pass</summary>[Bae2018.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001005#Files)</details>|FAIL|<details><summary>pass</summary>[Bae2018.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001005#Files)</details>|pass|pass|
|[BIOMD0000001006](https://www.ebi.ac.uk/biomodels/BIOMD0000001006)<br/><sup>Ciliberto2005 - Steady states and oscillations in the p53/Mdm2 network</sup>|<details><summary>pass</summary>[Ciliberto2005.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001006#Files)</details>|pass|<details><summary>pass</summary>[Ciliberto2005.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001006#Files)</details>|pass|pass|
|[BIOMD0000001008](https://www.ebi.ac.uk/biomodels/BIOMD0000001008)<br/><sup>Scaramellini1997 - Two-receptor:One-transducer (2R1T) model for analysis of interactions between agonists</sup>|<details><summary>pass</summary>[Scaramellini1997.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001008#Files)</details>|pass|<details><summary>pass</summary>[Scaramellini1997.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001008#Files)</details>|pass|<details><summary>FAIL (outOfRange)</summary>```list index out of range```</details>|
|[BIOMD0000001009](https://www.ebi.ac.uk/biomodels/BIOMD0000001009)<br/><sup>Zhang2007 - Mechanism of DNA damage response (Model2)</sup>|<details><summary>pass</summary>[Zhang2007_M2_low_dose.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001009#Files)</details>|pass|<details><summary>FAIL</summary>[Zhang2007_M2_high_dose.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001009#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Zhang2007_M2_high_dose.sedml```</details>|
|[BIOMD0000001011](https://www.ebi.ac.uk/biomodels/BIOMD0000001011)<br/><sup>Leon-Triana2020 - CAR T-cell therapy in B-cell acute lymphoblastic leukaemia</sup>|<details><summary>pass</summary>[Leon-Triana2020 (eqs 4).xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001011#Files)</details>|FAIL|<details><summary>pass</summary>[Leon-Triana2020 (eqs 4).sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001011#Files)</details>|pass|pass|
|[BIOMD0000001012](https://www.ebi.ac.uk/biomodels/BIOMD0000001012)<br/><sup>Leon-Triana2020 - CAR T-cell therapy in B-cell acute lymphoblastic leukaemia with contribution from immature B cells</sup>|<details><summary>pass</summary>[Leon-Triana2020 (eqs 3).xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001012#Files)</details>|FAIL|<details><summary>pass</summary>[Leon-Triana2020 (eqs 3).sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001012#Files)</details>|pass|pass|
|[BIOMD0000001014](https://www.ebi.ac.uk/biomodels/BIOMD0000001014)<br/><sup>Leon-Triana2021 - Competition between tumour cells and dual-target CAR T-cells</sup>|<details><summary>pass</summary>[Leon-Triana2021 (eqs 3-6).xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001014#Files)</details>|FAIL|<details><summary>pass</summary>[Leon-Triana2021 (eqs 3-6).sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001014#Files)</details>|pass|pass|
|[BIOMD0000001015](https://www.ebi.ac.uk/biomodels/BIOMD0000001015)<br/><sup>Jarrah2014 - mathematical model of the immune response in muscle degeneration and subsequent regeneration in Duchenne muscular dystrophy in mdx mice</sup>|<details><summary>pass</summary>[Jarrah2014.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001015#Files)</details>|pass|<details><summary>pass</summary>[Jarrah2014.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001015#Files)</details>|pass|pass|
|[BIOMD0000001016](https://www.ebi.ac.uk/biomodels/BIOMD0000001016)<br/><sup>Bakshi2020 - Truncated minimal model of alternative pathway of complement system</sup>|<details><summary>pass</summary>[Bakshi2020 truncated minimal model.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001016#Files)</details>|FAIL|<details><summary>FAIL</summary>[Bakshi2020 truncated minimal model.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001016#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Bakshi2020 truncated minimal model.sedml```</details>|
|[BIOMD0000001017](https://www.ebi.ac.uk/biomodels/BIOMD0000001017)<br/><sup>Bakshi2020 - Minimal model of alternative pathway of complement system</sup>|<details><summary>pass</summary>[Bakshi2020 minimal model.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001017#Files)</details>|FAIL|<details><summary>pass</summary>[Bakshi2020 minimal model.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001017#Files)</details>|pass|pass|
|[BIOMD0000001018](https://www.ebi.ac.uk/biomodels/BIOMD0000001018)<br/><sup>Bakshi2020 - Properdin model of alternative pathway of complement system</sup>|<details><summary>pass</summary>[Bakshi2020 properdin model.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001018#Files)</details>|FAIL|<details><summary>FAIL</summary>[Bakshi2020 properdin model.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001018#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Bakshi2020 properdin model.sedml```</details>|
|[BIOMD0000001019](https://www.ebi.ac.uk/biomodels/BIOMD0000001019)<br/><sup>Barros2021 - CARTmath, Mathematical Model of CAR-T Immunotherapy in HDLM-2 cell line</sup>|<details><summary>pass</summary>[Barros2021_HDLM2.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001019#Files)</details>|FAIL|<details><summary>FAIL</summary>[Barros2021_HDLM2.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001019#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Barros2021_HDLM2.sedml```</details>|
|[BIOMD0000001020](https://www.ebi.ac.uk/biomodels/BIOMD0000001020)<br/><sup>Barros2021 - CARTmath, Mathematical Model of CAR-T Immunotherapy in Raji Cell Line</sup>|<details><summary>pass</summary>[Barros2021_RAJI.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001020#Files)</details>|FAIL|<details><summary>FAIL</summary>[Barros2021_RAJI.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001020#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Barros2021_RAJI.sedml```</details>|
|[BIOMD0000001023](https://www.ebi.ac.uk/biomodels/BIOMD0000001023)<br/><sup>Alharbi2020 - An ODE-based model of the dynamics of tumor cell progression and its effects on normal cell growth and immune system functionality</sup>|<details><summary>pass</summary>[Alharbi2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001023#Files)</details>|pass|<details><summary>pass</summary>[Alharbi2020 - Fig 5.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001023#Files)</details>|pass|pass|
|[BIOMD0000001024](https://www.ebi.ac.uk/biomodels/BIOMD0000001024)<br/><sup>Chaudhury2020 - Lotka-Volterra mathematical model of CAR-T cell and tumour kinetics</sup>|<details><summary>pass</summary>[Chaudhury2020 Eq 4-5.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001024#Files)</details>|FAIL|<details><summary>pass</summary>[Chaudhury2020 Eq 4-5 - Fig 3(C) simulation.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001024#Files)</details>|pass|pass|
|[BIOMD0000001026](https://www.ebi.ac.uk/biomodels/BIOMD0000001026)<br/><sup>Kurlovics2021 - Metformin partitioning between plasma and RBC with independent Kin and Kout coefficients</sup>|<details><summary>pass</summary>[Kurlovics2021.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001026#Files)</details>|pass|<details><summary>FAIL</summary>[Kurlovics2021.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001026#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Kurlovics2021.sedml```</details>|
|[BIOMD0000001027](https://www.ebi.ac.uk/biomodels/BIOMD0000001027)<br/><sup>Zake2021 - PBPK model of metformin in mice: single dose peroral</sup>|<details><summary>pass</summary>[Zake2021_Metformin+Mice+PO.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001027#Files)</details>|pass|<details><summary>pass</summary>[Zake2021_Metformin+Mice+PO.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001027#Files)</details>|pass|pass|
|[BIOMD0000001028](https://www.ebi.ac.uk/biomodels/BIOMD0000001028)<br/><sup>Zake2021 - PBPK model of metformin in humans, single PO dose</sup>|<details><summary>pass</summary>[Zake2021_Metformin+Human+single+PO+dose.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001028#Files)</details>|pass|<details><summary>pass</summary>[Zake2021_Metformin+Human+single+PO+dose.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001028#Files)</details>|pass|pass|
|[BIOMD0000001029](https://www.ebi.ac.uk/biomodels/BIOMD0000001029)<br/><sup>Zake2021 - PBPK model of metformin in humans, eight PO administrations with 12h interval</sup>|<details><summary>pass</summary>[Zake2021_Metformin+Human+multiple+PO+dose.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001029#Files)</details>|pass|<details><summary>pass</summary>[Zake2021_Metformin+Human+multiple+PO+dose.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001029#Files)</details>|pass|<details><summary>FAIL (other)</summary>```duration and steps must be non-negative```</details>|
|[BIOMD0000001032](https://www.ebi.ac.uk/biomodels/BIOMD0000001032)<br/><sup>Al-Tuwairqi2020 - Dynamics of cancer radiovirotherapy - Phase II treatment</sup>|<details><summary>pass</summary>[Al-Tuwairqi2020 - Phase II radiovirotherapy treatment.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001032#Files)</details>|FAIL|<details><summary>FAIL</summary>[Al-Tuwairqi2020 - Fig8 simulation.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001032#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Al-Tuwairqi2020 - Fig8 simulation.sedml```</details>|
|[BIOMD0000001033](https://www.ebi.ac.uk/biomodels/BIOMD0000001033)<br/><sup>Almuallem2020 - Virus-macrophage-tumour interactions in oncolytic viral therapies</sup>|<details><summary>pass</summary>[Almuallem2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001033#Files)</details>|pass|<details><summary>pass</summary>[Almuallem2020 - Fig6.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001033#Files)</details>|pass|pass|
|[BIOMD0000001034](https://www.ebi.ac.uk/biomodels/BIOMD0000001034)<br/><sup>Bunimovich-Mendrazitsky2007 - Mathematical model of BCG immunotherapy</sup>|<details><summary>pass</summary>[Bunimovich-Mendrazitsky2007.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001034#Files)</details>|pass|<details><summary>pass</summary>[Bunimovich-Mendrazitsky2007 - Fig4.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001034#Files)</details>|pass|pass|
|[BIOMD0000001036](https://www.ebi.ac.uk/biomodels/BIOMD0000001036)<br/><sup>Cappuccio2007 - Tumor-immune system interactions and determination of the optimal therapeutic protocol in immunotherapy</sup>|<details><summary>pass</summary>[Cappuccio2007.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001036#Files)</details>|pass|<details><summary>FAIL</summary>[Cappuccio2007 - Fig1.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001036#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Cappuccio2007 - Fig1.sedml```</details>|
|[BIOMD0000001037](https://www.ebi.ac.uk/biomodels/BIOMD0000001037)<br/><sup>Alharbi2019 - Tumor-normal model (TNM) of the development of tumor cells and their impact on normal cell dynamics</sup>|<details><summary>pass</summary>[Alharbi2019 TNM.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001037#Files)</details>|pass|<details><summary>FAIL</summary>[Alharbi2019 TNM - Fig10.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001037#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Alharbi2019 TNM - Fig10.sedml```</details>|
|[BIOMD0000001038](https://www.ebi.ac.uk/biomodels/BIOMD0000001038)<br/><sup>Alharbi2019 - Tumor-normal-vitamins model (TNVM) of the effects of vitamins on delaying the growth of tumor cells</sup>|<details><summary>pass</summary>[Alharbi2019 TNVM.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001038#Files)</details>|pass|<details><summary>FAIL</summary>[Alharbi2019 TNVM - Fig11.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001038#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Alharbi2019 TNVM - Fig11.sedml```</details>|
|[BIOMD0000001039](https://www.ebi.ac.uk/biomodels/BIOMD0000001039)<br/><sup>Zake2021 - PBPK model of metformin in mice: single dose intavenous</sup>|<details><summary>pass</summary>[Zake2021_Metformin+Mice+IV.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001039#Files)</details>|pass|<details><summary>FAIL</summary>[Zake2021_Metformin+Mice+IV.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001039#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Zake2021_Metformin+Mice+IV.sedml```</details>|
|[BIOMD0000001040](https://www.ebi.ac.uk/biomodels/BIOMD0000001040)<br/><sup>Kurlovics2021 - Metformin partitioning from plasma to RBC,  single coefficient</sup>|<details><summary>pass</summary>[Kurlovics2021_single.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001040#Files)</details>|pass|<details><summary>FAIL</summary>[Kurlovics2021_single.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001040#Files)</details>|FAIL|<details><summary>FAIL (SEDMLfile)</summary>```failed to validate SEDML file Kurlovics2021_single.sedml```</details>|
|[BIOMD0000001041](https://www.ebi.ac.uk/biomodels/BIOMD0000001041)<br/><sup>Kimmel2021 - T cell competition and stochastic extinction events in CAR T cell therapy</sup>|<details><summary>pass</summary>[Kimmel2021.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001041#Files)</details>|FAIL|<details><summary>pass</summary>[Kimmel2021 - Fig2(a) and (b).sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001041#Files)</details>|pass|pass|
|[BIOMD0000001044](https://www.ebi.ac.uk/biomodels/BIOMD0000001044)<br/><sup>Csikasz-Nagy2006 - Mammalian Cell Cycle model</sup>|<details><summary>FAIL</summary>[Csikasz-Nagy2006.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001044#Files)</details>|FAIL|<details><summary>pass</summary>[Csikasz-Nagy2006.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001044#Files)</details>|pass|<details><summary>FAIL (CV_ILL_INPUT)</summary>```CVODE Error: CV_ILL_INPUT: One of the inputs to CVode is illegal. This includes the situation when a component of the error weight vectors becomes < 0 during internal time-stepping. It also includes the situation where a root of one of the root functions was found both at t0 and very near t0. The ILL_INPUT flag will also be returned if the linear solver routine CV--- (called by the user after calling CVodeCreate) failed to set one of the linear solver-related fields in cvode_mem or if the linear solver's init routine failed. In any case, the user should see the printed error message for more details.; In virtual double rr::CVODEIntegrator::integrate(double, double)```</details>|
|[BIOMD0000001045](https://www.ebi.ac.uk/biomodels/BIOMD0000001045)<br/><sup>Smith&Moore2004 - The SIR model for the spread of HongKong Flu</sup>|<details><summary>pass</summary>[Smith and moore2004-the SIR Model for Spread of Disease.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001045#Files)</details>|pass|<details><summary>pass</summary>[Smith and moore2004-the SIR Model for Spread of Disease.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001045#Files)</details>|pass|pass|
|[BIOMD0000001047](https://www.ebi.ac.uk/biomodels/BIOMD0000001047)<br/><sup>Collier1996 - Delta Notch intercellular signalling and lateral inhibition</sup>|<details><summary>pass</summary>[delta_notch.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001047#Files)</details>|pass|<details><summary>pass</summary>[delta_notch.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001047#Files)</details>|FAIL|pass|
|[BIOMD0000001048](https://www.ebi.ac.uk/biomodels/BIOMD0000001048)<br/><sup>Siddhartha2002 - Kinetic modelling of cancer therapies</sup>|<details><summary>pass</summary>[cancer_therapy.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001048#Files)</details>|pass|<details><summary>pass</summary>[cancer_therapy.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001048#Files)</details>|pass|pass|
|[BIOMD0000001052](https://www.ebi.ac.uk/biomodels/BIOMD0000001052)<br/><sup>Alharbi2020 - Tumor and immune system competition</sup>|<details><summary>pass</summary>[Tumor_cells_immune_system_competition.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001052#Files)</details>|pass|<details><summary>pass</summary>[Tumor_cells_immune_system_competition.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001052#Files)</details>|pass|pass|
|[BIOMD0000001053](https://www.ebi.ac.uk/biomodels/BIOMD0000001053)<br/><sup>Garde2020 - metabolic oscillations in Bacillus subtilis biofilms</sup>|<details><summary>pass</summary>[Garde2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001053#Files)</details>|pass|<details><summary>pass</summary>[Garde2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001053#Files)</details>|pass|pass|
|[BIOMD0000001054](https://www.ebi.ac.uk/biomodels/BIOMD0000001054)<br/><sup>Pearce2021 - Fibrin Polymerization</sup>|<details><summary>pass</summary>[fibrin_polymerization.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001054#Files)</details>|pass|<details><summary>pass</summary>[fibrin_polymerization.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001054#Files)</details>|pass|pass|
|[BIOMD0000001055](https://www.ebi.ac.uk/biomodels/BIOMD0000001055)<br/><sup>Jeon2018 - Enzyme clustering in Glucose metabolism</sup>|<details><summary>pass</summary>[Enzyme_clustering_in glucose_metabolism.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001055#Files)</details>|pass|<details><summary>pass</summary>[Enzyme_clustering_in glucose_metabolism.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001055#Files)</details>|pass|pass|
|[BIOMD0000001056](https://www.ebi.ac.uk/biomodels/BIOMD0000001056)<br/><sup>Chulian2021 - feedback signalling in B lymphopoeisis</sup>|<details><summary>pass</summary>[chulian2021.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001056#Files)</details>|pass|<details><summary>pass</summary>[chulian2021.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001056#Files)</details>|pass|pass|
|[BIOMD0000001057](https://www.ebi.ac.uk/biomodels/BIOMD0000001057)<br/><sup>Nikolov2020 - p53-miR34 model</sup>|<details><summary>pass</summary>[Nikolov2020.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001057#Files)</details>|pass|<details><summary>pass</summary>[Nikolov2020.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001057#Files)</details>|pass|pass|
|[BIOMD0000001058](https://www.ebi.ac.uk/biomodels/BIOMD0000001058)<br/><sup>Novak2022 - Mitotic kinase oscillation</sup>|<details><summary>pass</summary>[Novak2022.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001058#Files)</details>|pass|<details><summary>pass</summary>[Novak2022.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001058#Files)</details>|pass|pass|
|[BIOMD0000001059](https://www.ebi.ac.uk/biomodels/BIOMD0000001059)<br/><sup>Stucki2005 - caspase-3 metabolism</sup>|<details><summary>pass</summary>[Stucki2005.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001059#Files)</details>|pass|<details><summary>pass</summary>[Stucki2005.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001059#Files)</details>|pass|pass|
|[BIOMD0000001060](https://www.ebi.ac.uk/biomodels/BIOMD0000001060)<br/><sup>Frank2021 - Macrophage polarization</sup>|<details><summary>pass</summary>[Frank2021.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001060#Files)</details>|pass|<details><summary>pass</summary>[Frank2021.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001060#Files)</details>|pass|pass|
|[BIOMD0000001072](https://www.ebi.ac.uk/biomodels/BIOMD0000001072)<br/><sup>Phillips2013 - physiologically based modeling explaining Mammalian rest/activity patterns</sup>|<details><summary>pass</summary>[Phillips2013.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001072#Files)</details>|FAIL|<details><summary>pass</summary>[Phillips2013.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001072#Files)</details>|pass|pass|
|[BIOMD0000001077](https://www.ebi.ac.uk/biomodels/BIOMD0000001077)<br/><sup>Adlung2021 - Cell-to-cell variability in JAK2/STAT5 pathway</sup>|<details><summary>pass</summary>[Adlung2021 _model_jakstat_pa.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001077#Files)</details>|pass|<details><summary>pass</summary>[Adlung2021 _model_jakstat_pa.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001077#Files)</details>|pass|pass|
|[BIOMD0000001078](https://www.ebi.ac.uk/biomodels/BIOMD0000001078)<br/><sup>Hammaren-Geissen2022_PPToP_Model12</sup>|<details><summary>pass</summary>[Hammaren-Geissen2022_PPToP_Model12_withParameterSets.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001078#Files)</details>|pass|<details><summary>pass</summary>[Hammaren-Geissen2022_PPToP_Model12_withParameterSets.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001078#Files)</details>|pass|pass|
|[BIOMD0000001079](https://www.ebi.ac.uk/biomodels/BIOMD0000001079)<br/><sup>DeBoeck2021 - Modular approach to modeling the cell cycle, simple cell cycle model</sup>|<details><summary>pass</summary>[DeBoeck2021_cellcycle_bistableapc.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001079#Files)</details>|pass|<details><summary>pass</summary>[DeBoeck2021_cellcycle_bistableapc.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001079#Files)</details>|pass|pass|
|[BIOMD0000001080](https://www.ebi.ac.uk/biomodels/BIOMD0000001080)<br/><sup>DeBoeck2021 - Modular approach to modeling the cell cycle, 5 ODE model with 3 bistable switches</sup>|<details><summary>pass</summary>[DeBoeck2021_cellcycle_threeswitches.xml](https://www.ebi.ac.uk/biomodels/BIOMD0000001080#Files)</details>|pass|<details><summary>pass</summary>[DeBoeck2021_cellcycle_threeswitches.sedml](https://www.ebi.ac.uk/biomodels/BIOMD0000001080#Files)</details>|pass|pass|
